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Minister for Health Leo Varadkar welcomed the appointment, commenting ‘There is a lot of merit 
in appointing a cross-Departmental Minister 
for Drugs, as there is a significant overlap 
between Health and Justice in this area, 
ranging from treatment and prevention to 
enforcement and diversion. The new role will 
bring together the work and actions of the 
HSE and Gardaí among others.’ 
The Minister went on to note, ‘Aodhán 
is being appointed at a good time as the 
Department has just started work on the new 
National Drugs Strategy. Extra funding of 
€2.1m has been allocated in 2015 to provide 
Aodhán Ó Ríordáin TD
Mr Richard Guiney (Dublin Town), Mr 
Aodhán Ó Ríordáin TD, Minister of State with 
responsibility for the National Drugs Strategy 
and Dr Johnny Connolly (Health Research 
Board) at the inaugural Better City for All 
seminar in May.  
Minimum unit pricing  
for alcohol
See page 3
New Minister of State 
with responsibility 
for Drugs
In April 2015 Aodhán Ó Ríordáin TD was appointed Minister of State for the Drugs 
Strategy in the Department of Health. He is also Minister of State with responsibility 
for New Communities, Culture and Equality, which brief is spread across the 
Department of Justice and Equality and the Department of Arts, Heritage and 
the Gaeltacht.
more residential treatment and rehabilitation 
places, more needle-exchanges and the 
naloxone pilot project. I have also ended the 
cycle of cuts in funding for Local Drugs and 
Alcohol Taskforces.’ Minister Varadkar also 
noted the new Minister’s commitment to the 
equality agenda and his ‘excellent track record 
of community work’.
See separate report on ‘A Better City for All’ 
conference later in this issue for a report on one 
of the new Drugs Minister’s first public speaking 
engagements. 
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Alcohol Action Ireland conference
Alcohol Action Ireland held their conference Girls, women and 
alcohol: The changing nature of female alcohol consumption 
in Ireland on 21 April 2015 in Dublin. International and Irish 
speakers examined the factors influencing the changing 
culture of drinking among Irish girls and women, and the 
harms they are experiencing as a result.1 
Katherine Brown, director of the Institute of Alcohol 
Studies in the UK, described the changes in female alcohol 
consumption, from having a large role in the temperance 
movement to the ‘ladette’ drinking culture in the 1990s, 
and the recent rise of ‘mummy’s wine time’, whereby wine 
is now a socially acceptable coping mechanism for women 
trying to balance work and home life. She said we now live 
in an ‘alcogenic environment’, and outlined the role that 
marketing to women by the alcohol industry had played: 
alcohol is marketed to women as glamorous, sophisticated, 
feminine, sexy, often placed alongside lipstick, handbags 
and shoes.
Lucy Rocca, founder of Soberistas.com, spoke about this 
non-religious, peer support online resource for women with 
alcohol dependency issues. Within a year more than 20,000 
people had signed up to the site, many from Ireland.
Ann Dowsett Johnston, alcohol policy advocate and author 
of Drink: the intimate relationship between women and 
alcohol, said that women need to start thinking about their 
relationship with alcohol. Women tend to use alcohol to 
self-medicate and turn to alcohol rather than seek help for 
depression and anxiety. She stated that alcohol is too cheap, 
too accessible and too heavily marketed. 
Clíona Saidléar, executive director of the Rape Crisis Network 
of Ireland, highlighted the link between alcohol and sexual 
violence. She said there needed to be a refocus on the 
perpetrator of such violence and a move away from victim-
blaming. 
Dr Triona McCarthy, consultant in public health medicine 
with the HSE’s National Cancer Control Programme, spoke 
about the link between alcohol and cancer. She said that 
breast tissue is particularly susceptible to alcohol-related 
cancer and that women who drink a small glass of wine every 
day increase their risk of getting breast cancer by 7–10%. 
Dr Orla Crosbie, consultant gastroenterologist at Cork 
University Hospital, talked about the link between alcohol 
and liver disease. Liver cirrhosis is no longer a disease 
generally seen only in older Irish men.
(Deirdre Mongan)
1. The presentations may be viewed at http://alcoholireland.
ie/girls-women-and-alcohol-the-presentations/#sthash.
WM9snKrt.dpuf 
3drugnet 
Ireland
Alcohol pricing model applied to Ireland
40c 50c 60c 70c 80c 90c 100c 110c 120c 
Low risk 0.0% 0.0% -0.1% -0.3% -0.9% -1.9% -3.1% -4.5% -6.1% 
Increasing risk 0.0% -0.1% -0.6% -1.6% -3.2% -5.1% -7.2% -9.4% -11.7% 
High risk 0.0% -0.4% -1.4% -3.4% -6.8% -10.7% -15.1% -19.8% -24.4% 
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High risk -6.0% 0.0% -0.4% -1.4% -3.4% -6.8% -10.7% -15.1% -19.8% -24.4% -0.1% -3.0% 
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Figure 1: Effect of MUP on alcohol consumption by type of drinker
In 2013 the Sheffield Alcohol Research Group (SARG) 
at Sheffield University was commissioned by the Irish 
government to adapt the Sheffield pricing model for 
alcohol to Ireland in order to appraise the potential impact 
of different pricing policies. The report was published on 
11 March 2015.1 Some key findings from the report are 
presented here. 
Minimum unit pricing (MUP)
The first question posed was ‘What are the effects of 
introducing a legislative basis for minimum pricing per 10 
grams of alcohol or per standard drink, i.e. minimum unit 
pricing (MUP), in Ireland over a 20-year period?’ To answer this 
question, a pricing model was applied that used a simulation 
framework based on classical econometrics and cost-benefit 
analysis techniques. The methods are described in detail in 
the report. 
Two effects of interest are described here – alcohol 
consumption and individual spending. The effects of interest 
were examined by drinker type – low-risk, increasing-risk and 
high-risk. 
Prices of standard drinks
Prices vary by type of beverage. The evidence suggests 
that the impact of a potential minimum price of 90 cents 
or 100 cents for a standard drink will be greatest on beer, 
with average off-trade price increases of 31% and 44% 
respectively, followed by cider, with average increases of 
19% and 25% respectively. The lowest increases will be for 
wine and spirits, which will rise by an average of around 12% 
and 19% respectively (see Table 1). 
Alcohol consumption
MUPs below 70 cents are estimated to have a very small 
impact on alcohol consumption (see Figure 1). However, 
Figure 1 also shows how alcohol consumption across the 
overall population starts to reduce when the MUP is set at 70 
cents or higher (80c = -3.8%; 90c = -6.2%; 100c = -8.8%; 
110c = -11.7%). 
For a 100c MUP, the estimated per-drinker-reduction in 
alcohol consumption for the overall population is 8.8% 
and equates to an average annual reduction of 57.2 
standard drinks per drinker per year. As this is a targeted 
pricing policy, high-risk drinkers have larger estimated 
reductions in alcohol consumption as a result of an MUP 
policy than increasing-risk or low-risk drinkers. For example, 
the estimated reductions in consumption for a 100c MUP 
are 15.1% for high-risk drinkers, 7.2% for increasing-risk 
drinkers and 3.1% for low-risk drinkers (see Figures 1 and 2). 
These reductions correspond to an annual reduction of 494 
standard drinks per year for high-risk drinkers, 83.2 standard 
drinks for increasing-risk drinkers and 5.2 standard drinks for 
low-risk drinkers. 
Individual spending
Under an MUP policy, drinkers are estimated to reduce 
consumption but pay somewhat more on average for each 
standard drink consumed, and so the estimated percentage 
changes in spending are smaller than estimated changes in 
consumption (see Figure 3). The MUP policies are estimated 
to have small impacts on overall alcohol–related expenditure, 
for example expenditure will increase by 1.3% at 90c and 
100c MUP, and 1.1% at 110c MUP. 
For a 100c MUP, the estimated per drinker change in 
alcohol expenditure for the overall population is 1.3% and 
this equates to an average annual increase of €15.70. As 
this is a targeted pricing policy, high-risk drinkers will save 
€106.60 (-2.1%) each year as a result of an MUP policy, 
Alcoholic 
beverage
Average increase 
in off-trade price 
on foot of MUP set 
at 90 cents
Average increase in 
off-trade price on 
foot of MUP set at 
100 cents
Beer 31.5% 44.2%
Cider 19.4% 24.9%
Wine and 
spirits
12.2% 19%
Table 1: Impact of minimum pricing on off-trade prices 
of standard drinks
4drugnet 
Ireland
while increasing-risk drinkers will spend an extra €25.40 
(1.1%) per year on alcohol and low-risk drinkers will spend 
an additional €24.20 (4.8%). 
Value to society
For a 100c MUP policy, the total societal value of the harm 
reductions for health, crime and workplace absences is 
estimated at €1.7bn cumulatively over the 20-year-period 
modelled. This figure includes reduced direct healthcare 
costs, savings from reduced crime and policing, savings from 
reduced workplace absences and a financial valuation of the 
health benefits measured in terms of Quality-Adjusted Life 
Years (QALYs) valued at €45,000, in line with guidelines from 
the National Centre for Pharmacoeconomics on the cost-
effectiveness of health technologies. 
MUP and other pricing policies
In addition to understanding the impact of MUP in an 
Irish context, the Irish government wanted to know ‘How 
does MUP compare to, or enhance, other pricing policies?’ 
Specifically, how does MUP compare to, or enhance, other 
measures such as a ban on price-based promotions in the 
off-licence trade, a combination of MUP policies with a ban 
on price-based promotions, a ban on below-cost selling and 
a 10% price rise on all alcohol products. 
Ban on promotions
Banning all price-based promotions in the off-trade is 
estimated to reduce per-person alcohol consumption by 
1.8%. As this is a targeted pricing policy, high-risk drinkers 
have larger estimated reductions in alcohol consumption 
as a result of an MUP policy than increasing-risk or low-risk 
drinkers. For example, the estimated reductions are 3% for 
high-risk drinkers, 1.4% for increasing-risk drinkers and 0.7% 
for low-risk drinkers (see Figure 2). 
Under a promotions ban on trade retailers, drinkers are 
estimated to reduce consumption but pay somewhat more 
(0.6% or €7.20 each year) for alcohol consumed. As this 
is a targeted pricing policy, high-risk drinkers will spend 
an additional €11.40 (0.2%) each year as a result of the 
promotions ban while increasing-risk drinkers will spend an 
extra €13.00 (0.6%) on alcohol and low-risk drinkers will 
spend an additional €5.10 (1%) (see Figure 3).
Over the 20-year period modelled, the total societal value of 
the harm reductions resulting from a ban on promotions is 
estimated to be €0.38bn. This societal value equates to one-
third that of a 90c MUP. 
 
 
Figure 3: Relative effects of pricing policies on alcohol-related spending by type of drinker 
Alcohol pricing model (continued)
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Figure 2: Proportional (relative) effects of pricing policies on alcohol 
consumption by type of drinker
40c 50c 60c 70c 80c 90c 100c 110c 120c 
Low risk 0.0% 0.0% -0.1% -0.3% -0.9% -1.9% -3.1% -4.5% -6.1% 
Increasing risk 0.0% -0.1% -0.6% -1.6% -3.2% -5.1% -7.2% -9.4% -11.7% 
High risk 0.0% -0.4% -1.4% -3.4% -6.8% -10.7% -15.1% -19.8% -24.4% 
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Alcohol pricing model (continued)
National Community Action on Alcohol 
Pilot Project
In 2014 the Alcohol Forum, in partnership with the HSE and 
the Department of Health, initiated the National Community 
Action on Alcohol Pilot Project (NCAAPP).1 It aims to build the 
capacity of communities, through local and regional drugs 
and alcohol task forces (L/RDATF), to identify local alcohol-
related harm issues and priorities and to develop integrated 
local alcohol action plans. 
A community mobilisation approach is a priority theme cited 
in the National Substance Misuse Strategy:2 
There is a need for a community-wide, inclusive and 
coordinated approach to promote greater social 
responsibility and prevention and awareness raising on 
alcohol related issues. Communities should be supported 
to develop the evidence-based skills and methodologies to 
implement community mobilisation programmes with a view 
to increasing public awareness and discussion of alcohol 
problems, and to build community capacity to respond to 
alcohol problems at local level. (p. 27)
The National Substance Misuse Strategy also outlines how a 
public health approach is an appropriate response to reduce 
the harm from excessive consumption of alcohol in our 
communities and society as a whole. The local alcohol action 
plans developed under the pilot project will address the 
issues and priorities under the four national priority headings 
listed in the National Substance Misuse Strategy – supply, 
prevention, treatment and rehabilitation, and research.
The NCAAPP also supports the implementation of 
recommendations within the Healthy Ireland framework, 
under themes three and four – Empowering People and 
Communities, and Health and Health Reform.3 
Implementation
A steering group comprising representatives from the 
Alcohol Forum, the Drugs Policy Unit of the Department of 
Health, from Health Promotion and Improvement and Social 
Inclusion in the HSE, and from the Ballymun Alcohol Strategy 
group was set up to guide the NCAAPP.
The objectives of the project are to:
 ■ introduce a model of community action on alcohol  
to L/RDATFs;
 ■ raise awareness of the evidence of effective measures/
sustainable actions under each of the pillars – supply, 
prevention, treatment and rehabilitation and research – 
within L/RDATFs;
 ■ build awareness within L/RDATFs of alcohol prevention 
and related harm to both drinker and others;
 ■ explore effective measures to promote community 
engagement in the local action planning process;
 ■ develop an action planning template to assist 
communities to develop their own local alcohol action 
plan; and
 ■ ensure adequate monitoring, review and evaluation 
measures are built into the local plans.
L/RDATFs were asked to submit expressions of interest and in 
December 2014 six L/RDATF participants were selected:
 ■ North West Regional Drugs and Alcohol Taskforce,
 ■ Joint Initiative – Southern Regional Drug and Alcohol 
Taskforce and Cork Local Drugs and Alcohol Taskforce,
 ■ North Inner City Local Drugs and Alcohol Taskforce,
 ■ Tallaght Local Drugs and Alcohol Taskforce, and
 ■ Dun Laoghaire Rathdown Local Drugs and  
Alcohol Taskforce.
To date, each of the taskforces has formed an alcohol sub-
committee to work on the project and to engage with their 
community. Currently the Alcohol Forum is providing training 
to 20 representatives from the pilot projects and they in turn 
are linking back to their alcohol sub-committees and the full 
taskforce membership. It is planned that by early autumn 
2015 each participating taskforce will have developed a draft 
alcohol action plan for their area. 
An external evaluator has been engaged, following a tender 
process, to evaluate the effectiveness of the project and to 
use the findings to strengthen the project for roll-out in  
other areas. 
(Anne Timony Meehan & Suzi Lyons)
1. For further information visit http://af.mannadev.com/
national-community-action-on-alcohol-project/ or contact 
Anne Timony Meehan at anne@alcoholforum.org 
2. Department of Health (2012) Steering group report on a 
national substance misuse strategy Dublin: Department of 
Health. http://www.drugsandalcohol.ie/16908/ 
3. Department of Health (2013) Healthy Ireland – a framework 
for improved health and wellbeing 2013–2025. Dublin: 
Department of Health. http://www.drugsandalcohol.
ie/19628/ 
Ban on below-cost selling
A ban on below-cost selling is estimated to have minimal 
positive or negative impact on population consumption (see 
Figure 2), spending (see Figure 3), health outcomes and 
crime. It would save a cumulative €38.4m over 20 years.
Overall tax increase
The introduction of a 10% (tax) increase on the price of 
all types of alcohol (cheap and expensive) would decrease 
alcohol consumption for all drinkers by 5–6% and would 
affect low-risk, increasing-risk and high-risk drinkers equally 
(see Figure 2). It would have health benefits as well as 
reducing crime and workplace absences. The total societal 
value of the harm reductions arising from a general price 
increase over the 20-year period modelled is estimated at 
€1.6bn cumulatively.
(Jean Long)
1. Angus C, Meng Y, Ally A, Holmes J and Brennan A (2014) 
Model-based appraisal of minimum unit pricing for alcohol 
in the Republic of Ireland. University of Sheffield: ScHAAR. 
http://www.drugsandalcohol.ie/23904/
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Fianna Fáil publishes drugs action plan 
On 16 April 2015 Fianna Fáil launched a proposal for a 
Drugs Action Plan.1 In his Foreword to the plan, Fianna Fáil 
Spokesperson on Justice and Equality, Niall Collins TD, wrote 
about the drugs ‘crisis’ and the ‘inadequate response’ of the 
government; the Fianna Fáil web site hailed the plan as a 
‘radical new approach’. The plan reprioritises actions under 
the current policy framework.
Pointing to changes in the nature of the problem, 
including (1) a changing pattern of drug use, with alcohol 
and cannabis ‘causing problems for a vastly higher 
proportion of the population [than opiate addiction]’, (2) 
an over-concentration of resources in areas designated as 
disadvantaged, resulting in ‘huge geographical areas with 
no services at all’, and (3) new problems including the ‘new 
poor’ and ‘social problems such as mental health problems 
and co-occurring substance misuse issues manifest across the 
entire socio-economic spectrum’, the plan proposes a more 
equitable redistribution of resources between urban and rural 
areas, and between regional and local drugs and alcohol task 
forces, according to need.
Action plan
Under four themes, the action plan prioritises the need 
to strengthen the governance and co-ordination of drug 
policy, a stronger response to the needs of communities, 
a shift from a focus on medically-assisted treatment and 
maintenance to an emphasis on recovery, and the targeting 
of children and young people. 
New national substance misuse strategy
The action plan commits to implementing a ‘new national 
substance misuse strategy’ inclusive of all drugs and 
including alcohol and cannabis. The current Programme 
for Government already contains a commitment to publish 
a national substance misuse strategy that combines illicit 
drugs and alcohol. The proposed plan also commits to 
‘reappointing’ a Minister for Drugs and establishing a clear 
governance and co-ordination structure such as the former 
Office of the Minister for Drugs. Subsequent to the launch 
of the action plan, the Minister for Health announced the 
appointment of a dedicated Minister for Drugs (see item on 
page 1 of this issue of Drugnet). Co-ordination has long been 
recognised as critical for a cross-cutting issue such as illicit 
drug policy but it has proved difficult to do effectively.2 An 
Office of the Minister was briefly introduced by the Fianna 
Fáil–Progressive Democrats coalition government in 2010, 
but was disbanded a year later with the change  
of government.3 
Community impact and crime
Communities are a priority in the action plan. The plan 
commits to ensuring an equitable distribution of resources 
across all communities, both urban and rural, disadvantaged 
and advantaged, and not just for opiate-related problems 
but for problems associated with the ‘new poor’, with 
problems associated with alcohol, cannabis use, polydrug 
use and comorbidity. The plan also seeks to tackle the impact 
of the operation of the drugs market on communities, for 
example the effects of drug-dealing and -using, anti-social 
behaviour arising from drug use, drug-related intimidation, 
the exploitation of young children by drug users, and any 
negative consequences from having a drug treatment centre 
located in a community. These issues have been discussed 
and measures taken to address them in the current or the 
previous national drugs strategy, predominantly under the 
Supply Reduction pillar. 
Health, treatment and rehabilitation
The action plan commits to shifting from opiate substitution 
treatment to a recovery-focused approach. In describing 
the current policy approach, the plan states, ‘… seriously 
high levels of public funding has been dispersed via the 
HSE into methadone maintenance for opiate substitution 
in this country with little or no emphasis on progression, 
recovery or movement to drug free status for patients’ (p. 
2). Among the seven actions listed in relation to treatment 
and rehabilitation are calls for a shift away from opiate 
substitution treatment in methadone clinics to treatment in 
general practices; the establishment of community-based 
support services providing evidence-based assessment, 
case management and structured care planning using an 
integrated care model to tackle the problems associated with 
alcohol and cannabis use; a stronger emphasis on a recovery-
focused service, including a comprehensive after-care service 
and the creation of pathways to recovery. The increased 
interest reflects a trend seen in other jurisdictions including 
the USA, England and Scotland, and recently explored by 
members of the Oireachtas (Parliament).4
Children and young people
Children and young people are specially targeted in the 
action plan. Under the heading ‘Prevention and early 
intervention’, the plan lists four high-level actions focusing 
on school-children, children of drug misusers, and children 
and young people out of school. While this segmentation is 
similar to that in the current national drugs strategy (2009–
2016), the drugs action plan specifies different interventions.
Policy questions
Moving directly to the action level, Fianna Fáil forewent an 
opportunity to start a national debate on possible future 
directions for Ireland’s drug and addiction policies. Questions 
that might have been asked include:
 ■ What principles should underpin Ireland’s substance 
misuse policy – human rights, public health, social 
inclusion, reduction of supply, demand and/or harm?5 
 ■ What substances and/or behaviours should be included 
in a national substance misuse strategy? Ireland’s strategy 
has already been expanded to include not just controlled 
(illicit) drugs but also alcohol. In other countries the 
scope has expanded even further to fully embrace a 
public health approach to addictions, including not only 
all licit and illicit psychoactive substances, including 
tobacco as well as alcohol, but also addictive behaviours 
such as gambling, Internet addiction, eating disorders.6 
 ■ How should the supply of substances such as the two 
substances highlighted in Fianna Fáil’s action plan 
– alcohol and cannabis – be controlled? Both these 
substances are the subject of ongoing public discussion 
in Ireland. In November 2013 Dáil deputies debated a 
private member’s motion to regulate the cultivation, sale 
and possession of cannabis and cannabis products in 
Ireland. Although the motion was lost, there was support 
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for decriminalisation and for regulation.7 In February 
2015 the government released the General Scheme of 
the Public Health (Alcohol) Bill, intended to more strictly 
regulate the alcohol market.8 
 ■ What contribution will Ireland make to UNGASS 2016, 
the special session of the UN General Assembly due 
to be held in New York on 19–21 April 2016, to assess 
‘the achievements and challenges in countering the 
world drug problem, within the framework of the three 
international drug control conventions and other relevant 
United Nations instruments’?9
(Brigid Pike)
1. Collins N (2015) Drugs action plan. Dublin: Fianna Fáil 
http://www.drugsandalcohol.ie/23816/
2. Pike B (2008) Development of Ireland’s drug strategy 2000–
2007. HRB Overview Series 8. Chapter 4: ‘Implementing 
strategy’. Dublin: Health Research Board http://www.
drugsandalcohol.ie/11465/ 
3. Pike B (2011) Where do drugs fit in? Drugnet Ireland (37): 
3–4 http://www.drugsandalcohol.ie/14983/ and Pike B 
and Nelson M (2011) National drugs strategy goes to 
Department of Health Drugnet Ireland (38): 3–4  
http://www.drugsandalcohol.ie/15630/ 
4. Pike B (2014) Recovery in national drugs strategies. Drugnet 
Ireland (51): 8–10 http://www.drugsandalcohol.ie/22908/; 
Joint Committee on Health and Children (2015, 26 
March) ‘Drug addiction and recovery models: discussion’. 
Downloaded on 22 April 2015 at http://oireachtasdebates.
oireachtas.ie 
5. Pike B (2012) What makes for a ’good’ drugs policy? 
Drugnet Ireland (44): 11–13. http://www.drugsandalcohol.
ie/19134/ 
6. Pike B (2015) How does Ireland’s drugs policy compare 
with others? Drugnet Ireland (53): 4–5. http://www.
drugsandalcohol.ie/23687/ 
7. Pike B (2014) Dáil debate on cannabis. Drugnet Ireland (49): 
6–9. http://www.drugsandalcohol.ie/21673/ 
8. Department of Health (2015, 4 February) General Scheme 
of the Public Health (Alcohol) Bill 2015. Downloaded 
on 22 April 2015 at http://health.gov.ie/wp-content/
uploads/2015/02/General-Scheme-of-the-Public-Health-
Alcohol-Bill-2015.pdf
9. Since Issue 48, Drugnet Ireland has been carrying a column 
‘Towards UNGASS 2016’, which reports on policy initiatives, 
research and debates launched by UN member states and 
civil society organisations in the lead-up to UNGASS 2016.
FF drugs action plan (continued)
Changing drug trends but static policies 
On 21–23 May 2015 the International Society for the Study 
of Drug Policy (ISSDP) held its ninth annual conference, in 
Ghent, Belgium.1 Aileen O’Gorman of the University of the 
West of Scotland, Glasgow, United Kingdom, gave a paper 
at the conference based on a study of licit and illicit drug 
use patterns in the Finglas–Cabra local drugs task force area 
undertaken in the second half of 2012.2 The conference 
paper was titled ‘Changing drug trends: static drug policies’. 
The abstract of O’Gorman’s paper is reproduced below.3 
(Citations included in the abstract have been deleted as full 
publication details were not provided.)
Background
Since the 1990s, patterns and trends in drug consumption 
have evolved in response to global and local shifts in drug 
production and supply, and in response to fluctuating 
levels of demand influenced by accessibility, price, quality, 
and cultural appeal. The consumption of a combination of 
licit and illicit substances has become a regular feature of 
weekend and festive socialising among young people. ‘Illegal 
leisure’ had become normalised and accommodated into 
the social and cultural practices of different social groups 
[citations deleted], albeit on a differentiated basis [citations 
deleted]. Nonetheless, internationally, drug policy remains 
predominantly and intransigently prohibitionist, focused on 
criminalising users, curtailing supply, and preventing and 
treating addictions. The gap between drug policies and drug 
consumption practices is ever-widening.
Aims and methods
This paper draws from the findings of a recent 
neighbourhood study that explored drug consumption 
patterns, practices and meanings from the perspective of 
a group of young people ‘from the street’, whose public 
presence was often perceived as problematic and who were 
regarded as being ‘at risk’ through their drug use [citation 
deleted]. Data were collected through individual and focus 
groups interviews, and ethnographic observations and 
conversations in the drug users’ natural locations. The paper 
is further informed by a series of neighbourhood drug studies 
which began in Dublin in 1996 and have been conducted 
at intervals since [citations deleted]. These studies share a 
similar critical interpretivist methodological approach, which 
explored the lived experience of these drug users within a 
political economy framework of analysis of socio-spatial  
risk environments. 
Findings 
Patterns emerged from the drug enthusiasts’ narratives 
illustrating how drug consumption practices were shaped by 
different intentions mediated by time and space settings, and 
the negotiation of an intricate interplay between structure 
and agency. Drug intentions were a key influence on their 
consumption practices. These intentions ranged from 
‘chillin’, ‘buzzin’ and ‘getting mangled’ to ‘coming down’, 
and each intention was embedded in a set of polydrug 
combinations that included alcohol, cannabis, ecstasy, 
cocaine, new psychoactive substances, and prescription 
tablets (mainly benzodiazepines and so called ‘Z drugs’ such 
as Zimovane, Zopiclone etc.). 
The paper describes and analyses the users’ drug choices, 
intentions and risks, and situates them in the context of the 
role and meaning of drug use in their lives, including their 
participation in the drugs economy. Glimpses of rational 
action and cost-benefit analyses in their discourses of choice 
were seen to be brokered within short-term socio-temporal 
spaces and bounded by the broader social, cultural and 
policy contexts they inhabited. Drug users do not exist in 
isolation from their social, economic and policy contexts. The 
findings of this study highlight the need for integrated drug 
and social policies that address broader contextual structural 
issues and inequalities.
(Brigid Pike)
1. For more information on the ISSDP and its conferences, visit 
http://www.issdp.org/ 
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Ireland participates in innovative policy 
think-tank
Although the oldest international drug policy think-tank, the 
Pompidou Group, of which Ireland is a member, is arguably 
the most innovative intergovernmental body working in the 
area of policy on psychoactive substances and addictions 
in the world today. Its achievements over the past forty 
years are outlined in the following article. The new work 
programme for 2015–2018 has four thematic priorities:1
1. Bring human rights to the forefront
The Pompidou Group will support member states in meeting 
their obligations under the Council of Europe and United 
Nations Conventions to protect fundamental rights and 
freedoms, in particular the right to life and human dignity, 
the right to protection of health, the right to equitable 
access to quality health-care services for all, the prohibition 
of any type of discrimination as well as the right of children 
to be protected from narcotic drugs and psychoactive 
substances. Promoting gender equality will also continue to 
be a transversal aspect to be observed in all Pompidou Group 
activities. Aims include:
 ■ increasing awareness of human rights obligations and 
reduction in human rights violations occurring in the 
pursuit of drug policy goals; 
 ■ contributing to reducing stigmatisation  
and discrimination; 
 ■ promoting the right of access to healthcare for drug 
dependent people in detention; 
 ■ highlighting and recognising the pivotal role of the 
Pompidou Group, as a part of the Council of Europe, in 
promoting human rights as a fundamental drug policy 
principle; and
 ■ promoting the mainstreaming of gender aspects in all 
areas of drug policy. 
2. Analyse policy coherence, costs, impact 
and potentially adverse effects of drug policy 
measures 
Recognising that understanding the costs and effects of 
different policies not only in terms of their immediate impact 
but also in view of indirect effects and costs is necessary for 
making the right choices and for understanding the return 
on investment, the Pompidou Group is committing to 
supporting member states to take into account the whole 
spectrum of drug control costs, as well as the impact of drug 
control measures on different aspects of life and sectors of 
policy. At the same time the Pompidou Group will emphasise 
that policy coherence between policies on licit and illicit 
drugs, as well as addictive behaviours, is a fundamental 
determinant of cost effectiveness. Aims include:
 ■ better understanding of how to determine a balanced 
approach in drug policy and ensuring that different 
approaches complement each other; 
 ■ developing concepts for a cost benefit approach in drug 
policy planning; 
 ■ providing guidance for prioritisation in times of 
diminishing public funds; and
 ■ promoting more coherence between demand and supply 
reduction policies, and other policies. 
3. Address changing patterns and context of 
drug use, production and supply 
While the international drug control conventions offer the 
possibility of scheduling new substances, the Pompidou 
Group identifies the sheer rapidity of emerging new 
psychoactive substances, as well as the time-consuming 
and costly way of bringing them under control, as a specific 
challenge. Other challenges include the rapid spread of 
methamphetamines in some regions, the continuing high 
levels of cannabis consumption, the emergence of heroin in 
social contexts not previously seen, poly-drug use, including 
mixed consumption of licit and illicit substances, and 
addictive behaviours. 
The Pompidou Group will support the exploration of new 
ways in which demand reduction, supply reduction and risk 
prevention and harm reduction approaches can be adjusted 
or further developed while keeping in mind the need for 
coherence in policies. Aims include:
 ■ identifying feasible responses for effective prevention in 
changing environments; 
 ■ adapting and refining detection methods in trafficking; 
 ■ identifying new precursor products, means of production 
and means of precursor control; 
 ■ adapting and broadening the concept of risk prevention 
and harm reduction; 
 ■ developing concepts for adequate treatment and 
rehabilitation in pursuit of re-integration; and 
 ■ facilitating dialogue between governments, civil society, 
professional groups and other relevant stakeholders to 
prevent use and risks. 
2. O’Gorman A, Piggott K, Napier K, Driscoll A, Emerson D, 
Mooney R, Fennelly C, Gately P and Foley M (2013) An 
analysis of current licit and illicit drug use patterns in the 
Finglas–Cabra local drugs task force area. Dublin: Finglas/
Cabra Local Drugs Task Force. http://www.drugsandalcohol.
ie/20723/ 
3. The abstract was downloaded from the preliminary version 
of the book of ISSDP conference paper abstracts at http://
www.issdp2015.ugent.be/wp-content/uploads/2015/03/
book_of_abstracts_preliminary_version.pdff 
Drug trends & policies (continued)
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4. Identify opportunities and challenges for drug 
policies arising from the Internet
Recent developments in information and communication 
technologies (ICT) have enabled the emergence of a new 
global black market for drugs sales which is rapidly growing. 
Easy access and anonymity reduce the threshold to buy 
drugs via the Internet and have created new distribution 
channels and payment systems that present new challenges 
for law enforcement and customs. By the same token, the 
Internet can potentially reach large groups of youth at both 
local and global level, including those not currently reached. 
Offering treatment to drug users via the Internet is rapidly 
increasing; the Internet can also be used to offer specialised 
services in remote areas and provide a cost-effective way to 
support a large number of clients. Aims include:
 ■ charting and better understanding of developments in 
cyber space in view of opportunities and challenges for 
demand and supply reduction efforts;
 ■ increasing competences for concerned government 
agencies;
 ■ providing guidance where action is needed; and
 ■ promoting cooperation with relevant stakeholders from 
the private sector.
(Brigid Pike)
1. For further information on the Pompidou Group work 
programme 2015–2018: ‘Drug policy and human rights: new 
trends in a globalised context’ (P–PG/MinConf [2014] 4), visit 
http://www.coe.int/T/DG3/Pompidou/ 
Policy think-tank (continued)
What is the Pompidou Group?
The Pompidou Group is an intergovernmental drug policy 
think-tank and champion of evidence-based drug policy. 
Formed over 40 years ago, it has spearheaded many new 
initiatives subsequently taken over by other agencies. For 
example, the concepts of monitoring trans-national drug 
abuse and indicator development were introduced by the 
Pompidou Group, and then taken over by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
Methods to measure the use of alcohol, tobacco and drugs 
were developed by the Pompidou Group, and the European 
School Survey Project on Alcohol and other Drugs (ESPAD) is 
now an independent programme that serves governments in 
51 countries as the principal data source on drug-use trends.1
Pompidou Group extends its ‘sphere  
of influence’
 ■ 1971: The Pompidou Group (Co-operation Group to 
Combat Drug Abuse and Illicit Trafficking in Drugs) 
was formed at the instigation of the French President 
Georges Pompidou. Initially, this informal forum 
consisted of seven European countries – France, Belgium, 
Germany, Italy, Luxembourg, the Netherlands and the 
United Kingdom – looking to share their experience 
of combating drug abuse and drug trafficking. Ireland 
joined on becoming a member of the European 
Community in January 1973.
 ■ 1980: The Pompidou Group was incorporated into  
the institutional framework of the Council of Europe  
and cooperation was subsequently extended to  
include new countries. Today the Pompidou Group 
comprises 37 member states. (See separate box listing 
member countries.)
 ■ 1990s: The Pompidou Group began to extend technical 
co-operation to countries in central and eastern Europe 
which are not members of the Pompidou Group, most 
recently to Albania, Latvia and Ukraine. In addition, the 
Group began to invite non-European countries, such as 
Canada, the USA, Australia and Mexico, to take part in 
activities, as well as other international bodies such as 
the European Union, the European Commission and the 
EMCDDA. The Holy See also cooperates on an  
ad hoc basis. 
 ■ 2006: The Pompidou Group began developing co-
operation activities for and with non-member states 
from the Mediterranean Basin such as Algeria, Tunisia, 
Lebanon, Egypt and Jordan.
As its ideas have been taken up by other agencies, the 
Pompidou Group has had to reinvent itself, not least in 
the last four years. In wrapping up the 2010–2014 work 
programme during the French presidency of the Pompidou 
Group, Executive Secretary Patrick Penninckx described  
this reinvention:2
The Pompidou Group has a long tradition in Research, work 
in Prison settings, work with front line professionals, gender 
issues, training and capacity building. These traditions were 
re-invigorated with specific programmes. New areas were 
explored and flexible working methods introduced. We were 
all alert to new developments and reacted to them quickly. 
We provided a space to explore, to question, to debate. 
… The constructive interaction between all stakeholders 
created a favourable environment to work with trust and 
endeavour which allowed the Pompidou Group to develop 
and continue to provide added value to Member States.
Cleary the Pompidou Group continues to provide added 
value in the following fields: Providing a forum for open 
debate, linking policy, research and practice, playing 
a precursor role with innovative ideas together with 
multidisciplinary and transversal approaches, and acting 
as a bridge with the European neighbourhood through 
multi-lateral activities. 
Membership of the Pompidou Group (37)
Austria, Azerbaijan, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, 
France, Greece, Hungary, Iceland, Ireland, Israel, Italy, Liechtenstein, Lithuania, Luxembourg, Malta, Republic of 
Moldova, Montenegro, Morocco, Norway, Poland, Portugal, Romania, Russian Federation, San Marino, Serbia, 
Slovak Republic, Slovenia, Sweden, Switzerland, the Former Yugoslav Republic of Macedonia and Turkey
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The Pompidou Group (continued)
Table 1 illustrates how the Pompidou Group provides a 
unique forum in which countries can explore new ideas in a 
climate of openness and trust. Ireland has participated in a 
number of these activities, being represented either at official 
level or at non-official level, for example by an expert in a 
specialist field or by a member of a civil society organisation. 
(Brigid Pike)
1. For further examples, see B Pike (2010) Pompidou  
Group celebrates its first 30 years. Drugnet Ireland (34): 21 
http://www.drugsandalcohol.ie/13300/ 
2. For further information on the Pompidou Group and 
Inventory of activities and outcomes accomplished during the 
work cycle 2011–2014 , published by the Pompidou Group, 
visit http://www.coe.int/T/DG3/Pompidou/
Activities of Pompidou Group Participation by 
Ireland
Advancing policies 
	 Guidance for developing coherent policies for licit and illicit drugs X
	 Preventing risks and reducing harm linked to the use of psychoactive substances 
	 Road traffic safety and substitution treatment 
	 Education and training on substance use disorders 
Supporting law enforcement 
	 Drug control services at European airports and in general aviation (Airports Group) X
	 Prevention of drug precursor diversion 
	 e-Learning tools for prosecutors on drug precursor diversion 
	 Elaboration of a framework aimed at reducing drug supply on a world-wide scale 
	 Drug-related cybercrime 
Linking research with policy 
	 Experiences with integrated policies for licit and illicit drugs X
	 Optimising communication between research and policy makers on ESPAD 
	 Gender dimension of non-medical use of prescription drugs X
	 Review of national regulations on opiate substitution treatment 
	 European Research Register 
	 Cooperation with European Society for Social Drug Research (ESSD) X
Connecting policy with practice 
	 Executive training for drug policy managers X
	 EXASS Net 
	 Drug policy cooperation in South East Europe and the Balkans (SEE) 
	 European Drug Prevention Prize X
Building capacity 
	 Support for the development, implementation and review of national drug policies X
	 Implementing coherent drug strategies in Ukraine 
	 Co-operation Network in the Mediterranean Region on drugs and drug addiction (MedNET) X
	 Drugs in prisons 
	 Cooperation with the Confidence Building Measures (CBM) Programme of the Council  
of Europe 
Table 1: Pompidou Group activities, 2010–2014
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Patterns and trends in cigarette 
smoking in Ireland, 2003–2013
A cigarette smoking prevalence tracker survey has been 
conducted in Ireland since 2002. Initiated by the Office of 
Tobacco Control, when this office was dissolved in 2010 
the survey was continued by the Health Service Executive. 
The survey involves a monthly, nationally representative 
telephone poll of 1,000 randomly selected people aged 15 
years and over.
The smoking prevalence question in the survey is ‘Do you 
smoke one or more cigarettes each week, whether packaged 
or roll your own?’ In addition, demographic information on 
gender, age, socio-economic group and region is collected. 
The basic information from the survey has been available 
in previous years. However, in 2014 the HSE published 
a detailed report on the patterns and trends up to and 
including 2013.1 
Results outlined in the report show that the overall 
prevalence of cigarette smoking in 2013 was 21.5%. This 
was higher among men (22.9%) than women (20.2%). 
Smoking was most prevalent among the 18–24-year-old age 
group (30.7%), followed by the 25–34-year-old age group 
(28.1%). The lowest prevalence was among those aged 65 
and older (9.7%). Of note, the prevalence among those 
aged 15 to 17 years was 13.3%.
The highest prevalence rates were found among the lower 
socio-economic groups (C2 and DE) at 24.6% and 25.9% 
respectively. The lowest rates were among higher socio-
economic groups (AB) at 13%, and farmers at 15%. There 
was very little difference in smoking rates by region.
An analysis of trends showed that overall cigarette smoking 
rates had declined by 6.6% since 2003, which equates 
to more than 104,000 fewer smokers in Ireland in 2013. 
This decline was evident in all age groups but was most 
pronounced in the 25–34-year-old age group (16.1%) and 
least evident in the 15–17-year-old age group (1.5%). All 
socio-economic groups have seen a downward trend since 
2003. The largest decreases were in the C2 group (11.1%) 
and the AB group (10.2%), with the smallest decrease 
among farmers (0.7%).
Trends in daily consumption of cigarettes, by category of 
smoker, were also reported. While regular smokers have 
consistently been the largest group since 2003, there is a 
trend towards lower levels of consumption. In 2013, 57.5% 
of all smokers were in the occasional or light categories. 
Moreover, in the last two years there has been a decrease in 
the proportion of regular smokers, from 39.8% to 36.2%, 
and a 3% increase in the number of occasional or light 
smokers. Heavy smokers have declined by 2%. 
(Margaret Curtin)
1. Hickey P and Evans DS (2014) Smoking in Ireland 2013: 
synopsis of key patterns and trends. Dublin: Health Service 
Executive. http://www.drugsandalcohol.ie/23200/ 
Categories of smoker
Category Cigarettes per day 
Occasional 1–5 
Light 6–10
Regular 11–20
Heavy 21+
Drug markets and the internet
The importance of the internet in the sale and supply of 
both licit and illicit drugs and new psychoactive substances 
(NPS) is reflected in the growing body of research literature 
dedicated to the investigation of this elusive market. The 
study of illicit drug markets has traditionally always been 
methodologically challenging, with researchers often 
having to negotiate access to buyers, sellers and drug law 
enforcement officials in order to gain insights into the largely 
hidden behaviour surrounding drug transactions.1 And 
now, the growing role of the internet in facilitating the illicit 
sale and supply of controlled drugs, and new psychoactive 
substances (NPS), is transforming the illicit drug market in 
ways that pose new challenges for law enforcement, public 
health, research and monitoring. The three studies reported 
here give an insight into the challenges. 
An EMCDDA study, undertaken in September–October 
2014, aimed to increase understanding of the online 
supply of drugs and to map the range of drug markets in 
existence.2 A specific focus was on ‘the role of social media 
and apps; online sale of NPS; online sales of medicinal 
products for illicit use; and the sale of drugs on the deep 
web’ (p.3). The study was based on a literature review and 
an international meeting of experts who provided insights 
from information technology, research and monitoring, 
law enforcement, internet and drug user perspectives. It 
looked at the role of social media, which operate mostly on 
the ‘surface web’, in drug markets, for example Facebook 
(1.6 billion registered users), YouTube (1 billion active 
users) and Twitter (500 million registered users). It was 
reported that social media play a role in the sale of NPS, 
research chemicals, medicines such as lifestyle products 
(for erectile dysfunction, slimming or hair restoration) and, 
more recently, performance enhancement products and 
controlled prescription drugs such as benzodiazepines. The 
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Drug markets & the internet (continued)
Young people in drug treatment 
Darker and colleagues report on research undertaken with 
20 young people aged 15–19 years who were recruited 
from two addiction treatment programmes in Ireland – a 
residential programme in the south-east and an out-patient 
programme in Dublin.1 Data were collected using in-depth 
interviews and analysed using thematic analysis. 
Initial substance use
Factors reported by respondents as having contributed to 
their initial use of substances were grouped by the authors 
as either personal factors or environmental factors. Using 
substances as a coping strategy or a means of escaping 
emotional difficulties were the most common themes 
reported under personal factors. Participants recalled using 
substances to cope with family dysfunction, including 
domestic violence, and with inter-personal difficulties at 
school. Other personal stressors leading to initial substance 
use included family bereavement, relationship break-
up, being bullied, being placed in care and episodes of 
depression or anorexia. Some participants reported using 
substances to increase confidence and improve self-esteem.  
 
Environmental factors contributing to initial substance use 
were friends’ substance use and a family history of substance 
use. Young people described substance use as a normative 
experience, citing use by peers and influential elders as 
rendering use acceptable. The neighbourhood was also 
a factor, with access to substances having been easy and 
alternative recreational resources limited. 
Problematic substance use
All participants were engaged in problematic substance use 
to a level requiring specialist treatment. Their responses to 
how they progressed to this stage were grouped by the 
authors of the research under substance-related factors, 
substance use as a coping strategy and other factors. 
Participants reported experiencing cravings, withdrawal 
symptoms, hangovers, come-downs and other consequences 
of use, all indicating a cycle of addiction; increased tolerance 
and a growing desire to be high were other substance-
related factors contributing to progression to problematic 
use. Participants reported continued and increased use of 
substances as a means of coping with family dysfunction and 
a myriad of personal life stressors, including family illness 
or death. Other factors cited by some participants included 
criminal justice problems and problems at school. 
study also investigated law enforcement responses to online 
drug supply, and reported that they are focused on market 
disruption through measures such as reducing ‘trust around 
anonymity’, and on covert operations seeking to infiltrate 
online markets. Finally, the study considered the ‘deep web’, 
defined as a part of the internet not accessible to traditional 
search engines such as Google, and the ‘dark web’, defined 
as a small portion of the deep web intentionally hidden and 
inaccessible through standard web browsers.
The dark web is the focus of a recent policy briefing.3 
The sale of illicit substances on dark net drug markets has 
grown rapidly in recent years, facilitated by the release of 
The Onion Router (TOR) in 2002, which is ‘a technology 
that bounces internet users’ and websites’ traffic through 
“relays” run by thousands of volunteers around the world, 
making it extremely hard for anyone to identify the source 
of the information or the location of the user’ (p. 5). The 
policy briefing discusses the limitations of traditional law 
enforcement strategies in ‘matching, let alone exceeding the 
sophistication and innovation of the hidden web and digital 
crypto-currencies used for payment on the Dark Net drug 
markets’ (p. 2). The authors raise a number of points for 
policy-makers to consider:
 ■ For vendors and purchasers hidden markets present a 
safer environment for drug transactions and they reduce 
the multiple risks (coercion, violence, arrest, exposure to 
other drugs) associated with street sales.
 ■ Anonymised user forums and online chat rooms 
encourage and facilitate information-sharing about drug 
purchases and effects, representing a novel form of harm 
reduction for drug users and an entry point for drug 
support services.
 ■ Enforcement efforts through surveillance, hacking  
and other forms of interdiction may be successful 
in closing down a particular site, but at the cost of 
proliferating hidden drug markets and incentivising 
technological innovation.
Given the technical and legal challenges facing law 
enforcement in this area, the authors conclude that ‘Dark 
net interdiction efforts should prioritise high-end crimes such 
as child sexual exploitation, cyber terrorism and weapons 
trafficking, and work with self-regulating “ethical” drug sites 
to enhance understanding of high-level criminality on the 
dark net’ (p.1). The forthcoming 2016 UN General Assembly 
Special Session (UNGASS) on the world drug problem 
provides the opportunity, they suggest, to discuss how to 
‘better deal with the challenges of the increasingly complex 
illicit drug market in the twenty-first century’ (p.1).
That these challenges are likely to intensify in the years 
ahead is reflected in the findings of the latest update from 
the EU Early Warning system on NPS, published in March.4 
It is reported that over the past five years there has been an 
‘unprecedented increase in the number, type and availability 
of NPS in Europe’.
(Johnny Connolly)
1. See Ritter A (2006) Studying illicit drug markets: disciplinary 
contributions International Journal of Drug Policy (17): 
221–228. For recent Irish research, see Connolly J and 
Donovan A (2014) Illicit drug markets in Ireland. Dublin: 
National Advisory Committee on Drugs and Alcohol. http://
www.drugsandalcohol.ie/23302/
2. EMCDDA (2014) The internet and drug markets. Summary 
of results from an EMCDDA Trendspotter study. http://www.
drugsandalcohol.ie/23352/
3. Buxton J and Bingham T (2015) The rise and challenge of 
dark net drug markets. Global Drug Policy Observatory. 
Wales: Swansea University. http://www.drugsandalcohol.
ie/23274/
4. For more information on the EU Early Warning System, 
established in 1997 to gather and report data on NPS from 
the 28 EU members states, Turkey and Norway, see emcdda.
europa.eu/activities/action-on-new-drugs
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Young people in treatment (continued)
Hazardous alcohol consumption among 
university students
A recently published paper reports on a study undertaken 
with a sample of 2,275 undergraduate students at University 
College Cork. The aim of the study was to investigate the 
prevalence of hazardous alcohol consumption (HAC) and the 
associated adverse consequences among university students 
in Ireland, with particular reference to gender differences.
A questionnaire, based on previously validated instruments, 
was distributed to students during lecture time between 
12 and 23 March 2012. HAC was estimated using the 
Alcohol Use Disorder Identification Test for Consumption 
(AUDIT-C), developed by the WHO: it measures frequency 
of consumption, number of units consumed and number of 
binge drinking occasions. The study took into account the 
fact that guidelines for safe alcohol consumption are lower 
for women owing to their increased vulnerability to alcohol-
related harm. Body-mass index was estimated based on self-
reported height and weight. Logistic regression analysis was 
used to estimate factors associated with HAC for both men 
and women.
The study found that the prevalence of HAC was similar in 
men (65%) and women (67%) and was considerably higher 
than that previously reported in the general population. 
Moreover, 57% of women were drinking at a level that 
would be considered hazardous for men. Over one quarter 
of hazardous drinkers were consuming more than six units of 
alcohol (binge drinking) at least 2–3 times per week. Factors 
associated with HAC were studying law and business, not 
owning a house, current smoking, illicit drug use and being 
sexually active.
The pattern and frequency of adverse consequences of 
alcohol consumption were broadly similar for men and 
women. However, men were more likely to report getting 
into a fight and having a one-night stand than women. 
Among those with a HAC pattern, missing days at work or 
college as a result of drinking was reported by 60% of men 
and 57% of women, compared to 15% of men and 14% 
of women in the non-HAC student population. Hazardous 
drinkers were also more likely to engage in unplanned sexual 
activity and were less likely to use protection. 
Results show that patterns of alcohol consumption in these 
Irish university students are similar to those among British 
students but significantly higher than among students in 
the USA. Moreover, this paper highlights the association 
between HAC and the 12–month prevalence of illicit drug 
use. The authors state that these two behaviours need to be 
tackled concurrently.
The authors conclude that HAC continues to be a public 
health concern in Irish universities both in terms of 
immediate adverse consequences and long-term risks to 
physical and mental well-being. 
(Margaret Curtin)
1. Davoren MP, Shiely F, Byrne l and Perry I J (2015) Hazardous 
alcohol consumption among university students in Ireland: 
a cross-sectional study. BMJ Open, 5 (e006045) 
Coping with problems and stress
A common theme to emerge from respondents was their 
reliance on alcohol and drugs before they entered treatment 
to cope with problems and stress. Some also reported trying 
to avoid coping, or using emotion-focused coping such as 
getting angry and aggressive when under stress. 
Parental roles
Responses about the roles played by parents in the initiation 
and development of problematic substance use among 
participants were grouped under the following themes: 
relationship difficulties, enabling behaviour, parents’ 
permissive attitude and parents’ own substance misuse. 
Relationship difficulties appeared to arise through resistance 
to mothers’ efforts to control respondents’ problem 
behaviour and through lack of emotional support from some 
fathers; these experiences contributed to disengagement, 
anger and frustration among respondents. Parents’ lack of 
boundary-setting and giving money to respondents were 
perceived as enabling substance use, and parents’ tolerance 
of and participation in respondents’ alcohol consumption 
gave the impression of a permissive attitude. Parents’ own 
substance use was a factor that overlapped with many other 
factors reported by respondents. 
Conclusion
As noted by the authors, this is a small study of 20 young 
people attending treatment for substance use. It was 
designed to provide an insight into the factors that influence 
young people to use substances and the factors that 
contribute to use becoming problematic to the point where 
the young user needs specialist treatment. The findings 
should not be generalised to the wider population of young 
people in treatment. However, they may be used to inform 
the design and focus of further research that might test the 
relevance of these factors among a larger sample.
What is notable in the findings is the pivotal role played 
by the family in the young person’s initiation into 
and development of problematic substance use. The 
dysfunctional nature of the respondents’ families and their 
experience of parental conflict, violence and substance 
use, and the ensuing emotional trauma reported by them, 
appear to have been key ‘triggers’ in their decision to use 
substances. The authors point out that these young people 
used substances as the ‘default’ coping mechanism, but 
they did this in a context where the use of substances 
among significant others was perceived as the norm. These 
insights provide a useful basis for discussion about the 
design of effective prevention programmes. 
(Martin Keane) 
1. Darker CD, Palmer D, O’Reilly G, Whiston L and Smyth B 
(2014) Young people in drug treatment in Ireland: their 
views on substance use aetiology, trajectory, parents’ 
role in substance use and coping skills. Irish Journal of 
Psychological Medicine Available on CJO 2014 doi:10.1017/
ipm.2014.77 http://www.drugsandalcohol.ie/23180/
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Evaluating a substance use 
rehabilitation programme
In partnership with the UCD School of Applied Social Science 
Community Partnership Drugs Programme, the Ballymun 
Youth Action Project (BYAP) and partner agencies engaged 
in an evaluative research process of the Boxing Clever 
Programme in 2013/2014. The resulting report and the 
findings of this research project were launched on 6  
February 2015.1
The Boxing Clever programme is a 20-week integrated 
educational, substance use recovery and fitness  
programme that aims to support participants to develop 
more resilient identities, while encouraging educational 
achievement, physical wellness and reduction in harmful 
or risky behaviours. Seven organisations support the 
programme, with five of these organisations and eleven 
practitioners, including boxing coaches, directly involved in 
programme delivery. 
The research explored the impact and the outcomes of 
the programme for both participants and the community. 
Given the unique inter-agency structure of the programme, 
the research also investigated the efficacy of inter-
agency relationships and communication in delivering 
the programme. The research methodology comprised a 
literature review, a comparison of pre- and post-programme 
measures in regard to attitudes, behaviour, knowledge 
and physical fitness, focus groups with participants on the 
programme, and a qualitative exploration from a  
worker’s perspective. 
The authors of the report concluded that the research 
not only demonstrated the important role education and 
sport can play in substance use rehabilitation, but also the 
importance of inter-agency work in achieving the goals 
of rehabilitation and reintegration. The key findings are 
noted here.
Physical activity 
 ■ Positive changes occurred for the majority of participants 
in terms of physical endurance, core conditioning and 
upper body strength, and physical flexibility. 
 ■ Sport and physical exercise helped with improving mood.
 ■ The majority of participants completing the programme 
maintained their drug-free status or reduced their  
drug use, and attributed this to their participation in  
the programme.
Boxing skills
As well as developing boxing fitness and skills, the boxing 
element of the programme had other significant impacts:
 ■ Boxing facilitated and enabled the participants to socially 
re-integrate into their communities, communities that 
they were typically isolated or excluded from as a result 
their drug use. 
 ■ Boxing facilitated the release of anger and other 
emotions. Many of the participants lived in situations 
where personal and community violence were everyday 
risks, and the discipline and skills involved in the boxing 
element provided a way for participants both to defend 
themselves from violence and to express anger and  
other emotions. 
 ■ Boxing is a very individual sport. Boxers do not rely or 
use the skills of team members; their performance is 
completely down to them. While more challenging, 
this provides opportunities for personal growth, self-
awareness and self-knowledge. One practitioner noted 
that the relationship between a boxing coach and 
participant is intimate: if the intimacy is built on trust 
and respect, this can also result in positive change, self-
awareness and personal growth. 
 ■ The structure and approach of the boxing skills and 
fitness elements of the programme were designed and 
implemented to challenge gender norms associated with 
sports such as boxing. The research found that women 
both engaged, and sustained their participation, in  
the programme.
Education and social engagement
 ■ The programme supported and facilitated the majority of 
participants to achieve a QQI minor award at levels 4 and 
5, which is seen as a vehicle for further education.
 ■ The CASC element of the programme was pivotal in 
supporting participants to understand substance use 
within their family of origin and the wider community.
 ■ Participants reported positive changes as a result of 
participating in the programme, such as improved 
communication with their children and family. They 
also recognised the impact of their substance use on the 
community and a number identified this recognition as a 
motivator for sustaining positive change in their lives.
 ■ Participants valued the support of their mentors, who 
provided a concrete example of the possible progression 
onto further education, sport or community involvement. 
The practitioners found the mentoring role pivotal in 
supporting participants, informing participant support 
and illustrating the possibilities for progression. 
Inter-agency working
 ■ The research found the inter-agency working between 
the seven agencies was effective due to the presence 
of trust, respect, giving and taking, flexibility and open 
and clear communication. Rather than a competitive 
view of each other’s contribution, practitioners valued 
each other’s work, and were found to be flexible and 
adaptable. 
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 ■ Alongside the content and structure of the Boxing 
Clever programme, the inter-agency work supported 
participants through their change processes. Participants 
reported feeling valued, empowered and encouraged. 
The practitioners described how they sought to develop 
leadership, confidence and a sense of community 
belonging within the participants. This valuing of 
participants was also demonstrated in the resources 
and facilities allocated to the programme by all of the 
stakeholders.
The authors identified two major limitations to their research. 
(1) The sample size was small, with only 17 programme 
participants engaging in the research process. (2) The 
research considered the immediate impacts and outcomes 
for participants. The authors called for further research to 
consider the ‘long term impact and outcome of programmes 
that seek to build social and human capital, particularly those 
that utilise both fitness and education in the programme 
delivery’ (p. 57–58). 
(Brigid Pike)
1. Morton S, O’Reilly L and O’Brien K (2015) Boxing Clever: 
exploring the impact of a substance use rehabilitation 
programme. Dublin: Ballymun Youth Action Project.  
http://www.drugsandalcohol.ie/23545/ 
Motivational intervention for problem 
substance users in prison
The importance of drug treatment in prison is well recog-
nised, given the prevalence of problem substance use among 
prisoners. Engagement and retention in drug treatment is a 
key factor in improving outcomes. An evaluation of a group-
based motivational intervention, developed in order to iden-
tify and engage with substance users in a prison setting at an 
earlier stage with regard to their drug use, is described here.1 
The motivational intervention was based on motivational 
interviewing and the Prochaska and DiClemente transtheo-
retical model of behaviour change. Motivational interviewing 
is defined as ‘a client-centred directive method for enhancing 
intrinsic motivation to change by exploring and resolving 
ambivalence’. After the intervention the authors expected 
that participants would show: 
 ■ increased recognition of their problem behaviour,
 ■ decreased ambivalence towards their drug use, or
 ■ positive behavioural change in relation to their drug use.
Prisoners in Mountjoy prison who were current substance 
users were invited to participate in the intervention pro-
gramme. Those with active psychiatric illness or a release 
date before the end of the programme were not included. 
There were 76 potential participants: 44 were offered a place 
on the programme and 38 accepted. Each participant gave 
informed consent. Eleven potential participants were put 
on a wait list and formed the control group. The 12-session 
group-based motivational intervention took six weeks and 
each session lasted 1½ hours.
Demographic data, sentencing details, drug use history, risk 
behaviour and current engagement with treatment services 
were collected for each participant using a semi-structured 
interview. The primary outcome measure of treatment ef-
fectiveness was collected using the internationally validated 
questionnaire – Stages of Change Readiness and Treatment 
Eagerness Scale (SOCRATES).2 This measures a participant’s 
readiness for change. It was filled out by the participant (self-
reported) before and after the treatment. Retention rates in 
the programme were 88% at two weeks and 76% (n=31) at 
six weeks. Information on the seven who had dropped out 
by the sixth week was not included in the final analysis. 
The mean age of the participants was 31 years and all were 
male. Most were incarcerated for non-violent drug crimes 
(39%), followed by violent crime (35%). Opiates were the 
main drug used (71%). Three quarters (74%) reported ever 
injecting while nearly half (48%) reported recent injecting 
drug use. No statistically significant difference was found be-
tween the characteristics of the participants and the control 
group. 
Reported limitations of the study included small sample size, 
lack of randomised or treatment-as-usual control group, and 
use of self-reported outcome measures. Many of the par-
ticipants and those in the control group were also engaged 
in other prison drug treatment services, e.g. methadone 
maintenance, which may indicate that they already had a 
higher degree of motivation than other prisoners who were 
not engaged with the services. 
The authors considered the high level of retention and 
completion rates in the programme very positive. There was 
a statistically significant reduction in the ambivalence of the 
participants around their drug use after the intervention. The 
authors concluded that group-based motivational interven-
tions could be useful in a prison setting but they require 
further investigation. 
(Suzi Lyons)
1. Harper S and O’Rourke A (2015) An evaluation of group-
based motivational intervention for substance misusers in an 
Irish forensic setting. Irish Journal of Psychological Medicine, 
early on-line http://www.drugsandalcohol.ie/23573/ 
2. Miller W and Tonigan J (1996) Assessing drinkers motivation 
for change. The Stages of Change Readiness and Treatment 
Eagerness Scale (SOCRATES). Psychology of Addictive 
Behaviours (10):81–89
Substance use rehabilitation (continued)
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Patients on methadone programmes, 
Wheatfield prison
Methadone maintenance treatment (MMT) became available 
through the Irish Prison Service in 2002. Wheatfield prison 
is a closed, medium-secure prison for men, with an official 
capacity of 700. On 3 October 2011, of the 664 prisoners 
in the prison, 119 (18%) were receiving MMT. The authors 
undertook a descriptive study of all 119 prisoners on MMT 
on that date, from the electronic medical records.1 The main 
characteristics are summarised below.
 ■ Mean age was 33 years (range 21 to 58 years).
 ■ 78% were classified as either medium or full security risk.
 ■ Mean sentence length was four years (range 1 month 
to 15 years); 2% were on remand; 44% were serving 
a sentence of one month to two years; and 34% were 
serving a sentence of three to six years.
 ■ Mean methadone dose was 55mg (range 4 mg to 180 
mg), and 62% were on 60mg or less.
 ■ 7% were HIV positive, and 7/8 of those who were HIV 
positive were on antiretroviral therapy.
 ■ 38% were hepatitis C positive, and none were on 
hepatitis C treatment at the time of the study.
 ■ 1% were hepatitis B positive; 7% were recorded as 
having a hepatitis B vaccination. 
 ■ 2% were being treated for active tuberculosis.
 ■ 50% were prescribed other psychotropic medication 
– 24% anti-depressants, 18% anti-psychotics, 7% 
hypnotics, and 1% mood stabiliser.
 ■ 16% were attending addiction counselling services.
The profile of the prisoners on MMT in Wheatfield – their 
drug use prevalence, demographic data, sentencing details, 
medical and psychiatric history – was similar to the profile of 
prisoners who participated in other studies on this topic. 
Given that 18% of the population of Wheatfield prison were 
on MMT the day of the study, the authors concluded that 
MMT is now a significant medical undertaking in the IPS. 
They highlighted several issues in the management of MMT 
in Irish prisons:
 ■ Viral screening: there were gaps in documentation of 
prisoner status with regard to HIV (33%), hepatitis C 
(29%), and hepatitis B (73%). Using only information 
on documented hepatitis C status, the authors found 
that 54% (45/84) of prisoners on MMT were hepatitis 
C positive. They highlighted the need for improved viral 
screening for this high-risk group. 
 ■ Methadone dosages: the authors explained the wide 
range in methadone dosages as being probably due 
to an older population, on extended sentences, who 
had stabilised their opiate use, often through an 
agreed gradually reduced methadone regime. The 
highest dosages were explained by well recognised 
pharmacokinetic interactions with TB medication, which 
necessitated higher dosages. 
 ■ Extended aftercare: the authors recommended extended 
aftercare for prisoners who voluntarily worked to reduce 
their methadone dosage in order reduce the risk of 
overdose. They highlighted the need for improved viral 
screening for this high-risk group.
 ■ Take-home naloxone: The authors highlighted the need 
for take-home naloxone for prisoners when released, to 
reduce the risk of fatal overdose and also to fast-track 
prisoners back into MMT where necessary. 
(Suzi Lyons)
1. Galander T, Rosalim J, Betts-Symonds G and Scully M 
(2014) A survey of patients on methadone programmes 
in Wheatfield Prison, Dublin, Ireland. Heroin Addiction 
and Related Clinical Problems 16(2): 17–22. http://www.
drugsandalcohol.ie/23736/ 
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Report of the Garda Síochána 
Inspectorate
The Garda Síochána Inspectorate was established under the 
Garda Síochána Act 2005, with a remit to ensure that the 
resources available to the Garda are used ‘so as to achieve 
and maintain the highest levels of efficiency and effectiveness 
in its operation and administration, as measured by reference 
to the best standards of comparable police services’.1 The 
implementation of the 200-plus recommendations of 
its latest report, Crime investigation, which consolidates 
outstanding recommendations from previous reports, could 
lead to the most fundamental reform of policing in the state 
since the foundation of An Garda Síochána in the mid-1920s 
– at least in terms of the way the policing service is internally 
organised and experienced by the public.2 
The report runs to 500 pages and recommendations 
are made in each of the 11 parts of the report – crime 
prevention, divisional policing, first response, incident 
recording, crime management, investigating crime, the 
victim experience, intelligence-led policing, investigation and 
detention of suspects, offender management and detecting 
and prosecuting crime. This article focuses on the key points 
made in reference to drug law enforcement, an aspect of 
policing that is relevant across most of the eleven areas.
The main focus of the report is on the policing of volume 
crime – assaults, burglary, domestic violence, vehicle crime 
and robbery. Such crimes are typically committed by 
prolific offenders and so ‘the targeting of police resources 
on hotspots, recidivist volume crime offenders and repeat 
victims can have a significant impact on crime levels and 
community safety’ (Introduction, p. 5). The Inspectorate 
carried out field visits to seven of the 28 garda divisions 
and to national units, and over 1,000 garda members 
were interviewed. Interviews with the Probation Service, 
HSE, Courts Service, County/City Managers, Joint Policing 
Committees and victim support groups were also conducted. 
Visits were made to the police services of Northern Ireland, 
England, Scotland, Wales and Denmark, and the US, 
Australian and New Zealand police services were  
consulted. Approximately 1,500 PULSE crime and  
incident records were examined.
Drugs as a trigger offence
Although drug offences were not one of the main categories 
of offence analysed in the report, the Inspectorate 
acknowledges that many volume crimes are carried out 
by prolific offenders who may commit crime to ‘fuel a 
drug habit’ (Part 2, p. 2). A difficulty in establishing the 
true nature of drug-related crime in Ireland relates to the 
absence of drug-testing upon arrest. In other jurisdictions 
police services test persons arrested for so-called ‘trigger 
offences’. These are usually acquisitive crimes such as 
burglary or robbery. A test can be conducted for six drug 
types with results in five minutes. This data can clarify the 
causes of crime and can be used for court purposes. It can 
also improve health care provision. The report calls for the 
mandatory drug testing of persons detained for ‘trigger 
offences’ (Recommendation 9.17). 
 
Health care and demand reduction in  
Garda stations
The Inspectorate recommends that the Garda engage with 
key partners to develop an effective drug arrest referral 
scheme for those detained in garda stations, whereby those 
with drug problems can be referred to treatment providers 
(Recommendation 9.7). The report highlights the trend in 
other jurisdictions for health services to take responsibility 
for commissioning medical care provision in police custody, 
including the employment of nurses to provide immediate 
care to detained person where needed. This has been found 
to improve health care and reduce criminal justice costs.
Crime victimisation and community impact
With regard to drug-related crime, recent research has 
highlighted the disproportionate impact it can have on 
specific communities, particularly those with embedded drug 
markets.3 The Inspectorate suggests that in order to reflect 
this community experience, the Garda Síochána should, 
in consultation with the Director of Public Prosecutions, 
‘consider the use of Community Impact Assessments’ 
(Recommendation 7.5). In some jurisdictions, senior officers 
can complete such an assessment and this can inform 
policy responses including restorative justice interventions, 
partnership activity to tackle issues raised by the community 
and sentencing. In the context of drug markets, such an 
approach could be of value in directing responses to towards 
the most harmful markets – those involving violence, or open 
drug dealing or those involving young people.
Community policing and partnership approaches
The report highlights a new community policing model 
introduced in the North Central Division, involving a 
focused engagement with local stakeholders. However, 
it also notes that across all garda divisions visited, the 
number of community gardaí had been reduced, with two 
divisions effectively having none. The removal of community 
gardaí in some districts was an indirect consequence of 
the introduction of a new garda roster in 2012; a further 
contributory factor was the lack of value that appears to 
be placed on community policing activity within the police 
service. Specialist garda units raised concerns that many 
of their tasks, ‘such as community officers running local 
events or attending meetings, are not recorded on any 
IT system; so that supervisors can view their good work 
that contributes to community safety’ (Part 2, p. 24). It is 
acknowledged internationally that partnership responses 
involving local communities and statutory agencies provide 
the most sustainable responses to crime issues. However, 
participants in community meetings attended by the 
Inspectorate said that recurring anti-social behaviour was 
not being effectively addressed by the gardaí. The report 
recommends that the Garda Síochána conduct a review of 
the use of anti-social behaviour legislation (Recommendation 
1.13). The report notes the often complex nature of such 
activity and the need for a partnership response. However, 
it highlights the absence of a statutory requirement among 
agencies to collaborate in tackling crime and disorder, with 
the consequence that partnership approaches across the 
divisions visited ‘operated in many different ways’, and that 
the ‘absence of a statutory footing for partnerships allows 
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some agencies to disengage from joint working’ (Part 1, p. 
10). The report highlights the importance of ensuring that 
Joint Policing Committees, established under the Garda 
Síochána Act 2005, ‘are fully engaged in crime prevention 
activity’ (Recommendation 1.14). 
Crime statistics and the Central Statistics Office
From an examination of entries on the Garda Síochána 
PULSE IT system, the report identifies a significant number of 
problems associated with non-recording of crime, inaccurate 
recording of detection rates and inappropriate criminal 
prosecutions where original offences are downgraded to less 
serious offences. This has implications in relation to drug-
related intimidation, where the victim might not want to 
make a written statement of complaint for fear of reprisal 
from the offender. The report reiterates the rule which is, if 
there is a reasonable probability that a crime has occurred, 
and no evidence to the contrary, then even if the victim 
does not want the matter taken any further, a crime should 
be recorded (Part 3, p. 27). The report recommends that 
a ‘national standard for incident recording’ needs to be 
introduced (Recommendation 3.32). 
In 2006, the responsibility for reporting crime was transferred 
to the Central Statistics Office (CSO). In order to address 
the deficiencies identified, the report recommends that the 
CSO should receive ‘all PULSE record incident data including 
non-crime categories to facilitate analysis and reporting of 
crime statistics’ (Recommendation 4.16), it should have 
a central role in the development of new crime counting 
rules (Recommendation 5.4) and the Department of Justice 
should initiate a process whereby the CSO would have a 
central role ‘towards the designation of a baseline year 
for crime recording’ (Recommendation 5.9). It also calls 
for the appointment of an independent body to conduct 
annual audits of incident and crime recording standards 
(Recommendation 5.10).
Prolific offenders and integrated offender 
management
Although the Garda Síochána operate a number of case 
management approaches to youth offenders and to 
prolific offenders who move across divisional and regional 
boundaries, the Inspectorate notes that this is limited in the 
Dublin Metropolitan Region: ‘Given the level of organised 
crime and gang related violence in and around Dublin, this is 
a missed opportunity…The Inspectorate visited two divisions 
in the DMR and found little evidence of co-ordinated plans 
to manage known prolific offenders who move across 
the city’ (Part 10, p. 6). Other jurisdictions in the UK and 
Europe operate integrated offender management (IOM) 
approaches. IOM involves the police, probation service, 
health service, prison service, housing and job seeker 
agencies in information sharing and joint assessment and 
planning to reduce offending. Sometimes agencies are co-
located, thereby facilitating joint working. One of the aims of 
such approaches is to ‘break the cycle of persistent or prolific 
offending, particularly where drug or alcohol addiction is 
a factor in offending behaviour’ (Part 10, p. 9). The report 
provides a description and positive evaluations of such 
schemes in Cardiff and Hertfordshire, in the UK. 
Adult cautions for drug possession offences
A significant drug-related recommendation in the report 
relates to the adult cautioning system. Adult cautions 
are used by most police services as an alternative way of 
dealing with an offender who may be a first –time offender. 
A person must admit the crime before the caution can be 
administered, and it is a formal process where bythe crime 
is then detected against them. This can prevent a lot of 
less serious crimes from reaching the courts. Although a 
caution system exists in Ireland for youth offenders and for 
some crimes committed by adults, adult cautions do not 
apply to drug possession offences. The Inspectorate states 
that, from interviewing garda members, some expressed 
‘strong feelings about taking a young person to court for a 
small amount of cannabis. … A court conviction for drugs 
can have enormous consequences and in some cases, 
members are not issuing a summons’ (Part 11, p. 16). As 
a consequence, audits of drug cases conducted by garda 
divisions and districts have found ‘large numbers of cases 
where drugs have been seized and no proceedings have 
been taken’. The Inspectorate recommends that the Adult 
Caution scheme should be extended to drug possession 
cases (Recommendation 11.9).
Some final remarks
The overarching recommendation in the report is that the 
Department of Justice and Equality establish and task a 
criminal service justice group, involving all agencies and 
stakeholders responsible for community safety in Ireland, 
with overseeing the implementation of the recommendations 
in the report. It also recommends the adoption of a new 
divisional model for delivering services, including for 
the deployment of specialist units such as drugs units 
(Recommendation 2.1). 
A central theme throughout the report is the need for an 
internal reorganisation of the police service, in particular 
through the better utilisation of police staff and a review of 
the new garda roster introduced in 2012, so as to release 
garda members for operational duties. The report concludes: 
‘From the analysis of deployment data and from field visits to 
divisions and national units, it is clear…that garda resources 
are not currently deployed in terms of policing need and 
crime levels’ (Part 2, p. 18). The Inspectorate recommends 
that the Garda Síochána should design a ‘national resource 
allocation model that allocates resources fairly and matches 
resources to policing needs’ (Recommendation 2.10).
Perhaps the most consistent demand from the public 
when asked, in a recent study of illicit drug markets in 
Ireland, what was needed in response to crime was more 
gardaí on the beat.4 According to the Chief Inspector, 
Robert K.Olson, this issue will be addressed further by the 
Inspectorate as part of a ‘forthcoming review of the entire 
structure and administration of the Garda Síochána under 
the Haddington Road Agreement’ (Foreword, p. ii). Along 
with the recommendations of this report, this process could 
begin to address this long-standing community concern 
about policing.
(Johnny Connolly)
1. See www.gsnisp.ie
2. Garda Inspectorate (2014) Crime investigation. Report of the 
Garda Síochána Inspectorate. Dublin: Garda Inspectorate. 
http://www.drugsandalcohol.ie/22967/ 
3. Connolly J and Donovan A (2014) Illicit drug markets 
in Ireland. Dublin: National Advisory Committee on 
Drugs and Alcohol/ Health Research Board. http://www.
drugsandalcohol.ie/22837/ 
4. Connolly J (2014) Illicit drug markets in Ireland Drugnet 
Ireland (52): 1–5. http://www.drugsandalcohol.ie/23302/ 
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Towards ‘a better city for all’ 
The issue of public substance misuse and anti-social 
behaviour in Dublin’s inner city, actual or perceived, has 
long been a source of media focus and public concern. In 
2011 a partnership of stakeholder representatives – drawn 
from local businesses, drug treatment providers, An Garda 
Síochána, local drugs task forces and service users – was 
formed to develop sustainable responses to the many 
factors contributing to the situation. In June 2012, following 
research and in-depth discussion over a number of months, 
a report, A better city for all, was published.1 The report 
made almost 60 recommendations in relation to treatment, 
rehabilitation, homelessness, alcohol supply, policing, 
planning and urban design, legislation and partnership. The 
members of the A better city for all (ABCFA) group agreed 
that the issue of substance-related anti-social behaviour was 
primarily a public health issue and any sustainable long-term 
solution could only be delivered in that context.2
Throughout 2013, an implementation committee, chaired 
by the Area Manager for Dublin City Council, progressed 
the implementation of the recommendations in the report. 
Following an evaluation of the process in January 2014, the 
ABCFA group agreed that it had taken the implementation of 
the recommendations as far as it could. It highlighted several 
outstanding issues:
 ■ Homelessness: The group called for the ‘Housing First’ 
model, which targets people rough-sleeping, to be 
introduced as a mainstream programme. 
 ■ Treatment: The group highlighted the cutbacks in 
daytime services and the need to facilitate and support 
existing structures and services. It also supported 
the establishment of residential crisis stabilisation/
detoxification units for people with problematic poly-
substance use (including alcohol) and multiple needs. 
The group also supported, in principle, the introduction 
of a safe-injecting facility pilot project, based on good 
practice. 
 ■ Public information/communication: The group called for 
a strategy to help address the negative perceptions of 
the city as an unsafe place. It stipulated that the strategy 
should be evidence-based and cover both about the 
nature of the problems and the existing responses to 
them.
The ABCFA group agreed that further progress in addressing 
the issues in the city would require stronger and more 
integrated participation by statutory bodies, including senior 
budget holders, and the establishment of a focused street-
outreach team to respond to the needs of some of the most 
marginalised individuals in the city centre. In early 2014, a 
Higher Level Statutory Group, comprising representatives of 
Dublin City Council, An Garda Síochána, the HSE and the 
Dublin Regional Homeless Executive, was established. Since 
September 2014 a street-level outreach team, led by the Ana 
Liffey Drug project and including community Gardaí and HSE 
workers, was formed to operate on a case management basis 
with individuals in need of particular social supports.
With the national commemorations in 2016 coming closer, a 
need was identified by those involved in the process to date 
for those frontline services responding to the ongoing social, 
health and economic issues and challenges in the city centre 
to maintain a partnership and communication network in 
order to deliver on the overall objectives of ABCFA (see box). 
In May 2015, to further these objectives, an inaugural ABCFA 
seminar was held. Presentations explored the challenges of 
introducing ‘Housing First’, and of responding to public drug 
Mr Aodhán Ó Ríordáin TD, Minister of State with responsibility for the National Drugs 
Strategy speaking at the inaugural Better City for All seminar in May.
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use in the city centre from the perspective of low-threshold 
services such as the Ana Liffey Drug Project and Merchants 
Quay Ireland. Richard Guiney of Dublin Town gave the local 
business community perspective. The seminar was attended 
by representatives of frontline services, including members 
of An Garda Síochána, throughout the city. Commenting in 
advance of the seminar, the Lord Mayor of Dublin, Christy 
Burke, said:
It is well documented that the city centre has addiction 
issues and related anti-social behaviour issues, it is an 
area that I am determined to see solutions.  I have made 
addressing these issues a focus of my term as Lord Mayor 
of Dublin. I welcome the Better City for All initiative, where 
agencies and stakeholders across the city are combining 
their knowledge and expertise to develop sustainable 
solutions. I would like to particularly praise the inclusiveness 
of this process and it is focusing on the needs of the most 
vulnerable in our society, I believe that by focusing on their 
needs at the core of all activities that we will find solutions.  
I would also like to acknowledge and commend the 
dedication and hard work of many of the frontline services 
that have been responding to the needs of some of the most 
marginalised of the city’s inhabitants.  It is only by all of 
the stakeholders working together that we can achieve the 
desired progress. 
Minister of State Aodhán Ó Ríordáin, who was attending his 
second event since being allocated special responsibility for 
the National Drugs Strategy, stated:
I am delighted to be working with the Better City for All 
initiative. As I said upon my appointment, I want to meet 
with the various stakeholders involved in this issue and 
discuss how we can best tackle drug addiction in this 
country.  My  Department  will  shortly  be  beginning a 
consultation process  on  the  new  Drugs Strategy and as 
a newly-appointed minister, my priority  is to listen to those 
who have more expertise in this area than I do, and feed 
their contributions into this process.
During his address to the seminar, the Minister indicated 
his interest in radical new drug reforms such as the 
decriminalisation of cannabis and the establishment in 
Dublin of a medically supervised heroin injecting facility to 
address public injecting and associated harms. 
(Johnny Connolly)
1. Strategic Response Group (2012) A better city for all: a 
partnership approach to address public substance misuse and 
perceived anti-social behaviour in Dublin city centre. Dublin: 
SRG. http://www.drugsandalcohol.ie/17769/
2. For further information visit http://www.abettercityforall.ie
3. The author of this article was the original independent  
chair of the Strategic Response Group that produced  
the ‘Better City for All’ report, and he chaired the  
inaugural seminar. To hear the seminar presentations,  
visit http://www.drugs.ie/multimedia/
Stanhope Alcohol Treatment Centre 
service report for 2013
The Stanhope Centre has provided help to problem 
alcohol users, gamblers and their families since 1977. It is 
a dedicated HSE alcohol treatment facility for the northern 
area of Dublin and extends as far as Balbriggan. However, 
the catchment area for Barrymore Residential Programme, 
which is offered by the Stanhope Centre, includes the greater 
Dublin area and counties Kildare and Wicklow. 
In recent years there has been a change in the type of client, 
with many now presenting with both problem alcohol use 
and a problem with other drugs. In 2013 the educational 
programmes were updated and extended to better meet the 
needs of the client population.
In 2013, 509 clients made contact with the centre, a small 
increase on 2012, and the demographic profile of the clients 
remained similar. Sixty-five per cent of clients were male 
and most (226, 45%) were aged between 35 and 50 years. 
In 2013, the majority of clients had previously attended the 
service. Owing to improved management of the waiting list, 
especially the implementation of a ‘call back’ procedure, the 
number of cancellations and ‘did not attend’ continued to be 
low – 7% of all appointments
The centre offers a range of outpatient programmes for 
clients with problem alcohol use with/without problem 
drug use, and also for family members of those with 
problem alcohol use. Individual counselling forms the 
therapeutic basis for clients’ engagement with the service. 
The therapeutic relationship begins with an assessment 
period and continues as a client moves through the stages of 
treatment (educational programmes, treatment programmes 
and aftercare). 
A better city for all (continued)
Guiding Principles and Objectives of A Better 
City for All
Responses should:
 ■ be coordinated and partnership-based,
 ■ be evidence-based,
 ■ complement and not duplicate other relevant 
policies
 ■ be measurable,
 ■ not make problems worse or simply shift them 
elsewhere,
 ■ reduce public fears and address perceptions of 
concern associated with clients receiving drug 
treatment,
 ■ decrease the visibility of substance misuse,
 ■ address negative perceptions of the city as an 
unsafe place to be, and
 ■ promote a balanced perspective on the issues.
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Stanhope also offers the Barrymore Residential Programme, 
which runs for five and a half weeks and provides treatment 
and support for clients who meet the diagnostic criteria for 
alcohol dependency with/without other problem drug use 
or gambling. The programme runs on average seven times 
a year. It includes group therapy, education and life-skills 
training. After completion, clients move on to a six-week 
relapse prevention group and to an afternoon or evening 
aftercare group. These groups give clients the opportunity 
to successfully navigate the early days of recovery following 
a residential programme. On average, the programme has 
52 clients a year, of whom approximately 73% complete 
the programme. In 2013 the outcomes continued to be 
positive after completion, with half of clients who completed 
the residential programme also completing 26 weeks of 
aftercare. 
For further information on the programmes offered by 
the Stanhope Alcohol Treatment Centre, see http://www.
stanhopeservice.com 
(Regina Bannigan, Senior Counsellor and Service Coordinator, 
Stanhope Centre, with assistance from Suzi Lyons, Health 
Research Board)
Evaluation of a mental health  
early-intervention programme  
for young people 
Jigsaw is an early-intervention mental health service 
developed by Headstrong, the national centre for 
youth mental health. The service currently operates in 
10 communities across Ireland and is staffed by multi-
disciplinary teams of allied health professionals. The service 
targets young people aged 12–25 with mild and emerging 
mental health problems; young people presenting with more 
serious mental health problems are referred to other services. 
Jigsaw was developed to fulfil three objectives:
1. ensure access to youth-friendly, integrated and 
community-based mental health support, 
2. build capacity of frontline workers and volunteers, and 
3. promote community awareness around mental health.
It is estimated that more than 8,000 young people have 
received a service from Jigsaw. 
Data have recently been published on the profile of young 
people presenting to Jigsaw, the services they receive and a 
before-and after-comparison on the severity of their mental 
health problems.1 Data were collected from young people 
(n=2,420) who received support from Jigsaw from 1 January 
to 31 December 2013. Fifty-one per cent (n=1,237) received 
brief interventions comprising 1–6 sessions of goal-focused 
therapeutic support; 34.3% (n=829) received indirect 
support through services engaging with their parents and 
other professionals about their mental health needs; and 
14% (n=354) had brief contact with the Jigsaw service 
but their mental health needs exceeded the scope of the 
services provided by Jigsaw. The majority (56.5%, n=1,367) 
presenting to Jigsaw in 2013 were female and the most 
frequent users were aged 15–17 years. Almost a third of the 
1,608 young people (31.3%, n=504) who engaged directly 
with the service self-referred; this cohort included those 
receiving brief interventions and those who were  
brief contacts. 
Young people presenting to the Jigsaw service reported 
a large number of mental health problems (see Table 1). 
Anxiety was the most common mental health problem. 
Presenting problem Males n (%) Females n (%)
Anxietya 329 (31.2) 489 (35.8)
Angera 277 (26.3) 232 (17.0)
Family problems 217 (20.6) 289 (21.1)
Isolation from others 204 (19.4) 285 (20.8)
Feelings of depression 191 (18.1) 282 (20.6)
Stress 176 (16.7) 246 (18.0)
Parent/youth conflict 170 (16.1) 226 (16.5)
Sleep changes 165 (15.7) 253 (18.5)
Feelings of sadness/lossa 129 (12.3) 233 (17.0)
Drug usea 128 (12.2) 40 (2.9)
Thoughts of hurting selfa 118 (11.2) 228 (16.7)
Low self-esteema 103 (9.8) 248 (18.1)
Source: O’Keeffe et al (2015) 
a Denotes a significant difference between males and females
Stanhope Alcohol Treatment Centre (continued)
Table 1: Most common presenting issues for males (n = 1,053) and females (n = 1,367) in 2013
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Levels of psychological distress were assessed in young 
people via a brief intervention using the Clinical Outcome 
Routine Evaluation (CORE) questionnaires, either the CORE 
10 or the YP-CORE. The CORE questionnaires are validated 
instruments and were used to assess symptoms of anxiety 
and depression, and associated aspects of social functioning. 
Questionnaires were completed by 709 young people at 
their first session, and by 315 young people at their final 
session. The authors report that 89% presented to Jigsaw 
with clinical levels of psychological distress pre-intervention, 
and 52% reported moderate/severe or severe levels of 
distress. After engaging with Jigsaw, 47.2% had healthy, and 
28.8% had low, levels of psychological distress. 
The authors acknowledge the limitations of this study in that 
‘…self-reported levels of distress should be interpreted with 
caution as a multitude of other influences on young people’s 
lives make it difficult to attribute any change directly to the 
use of a specific service…’. (p. 76) 
Commentary
This retrospective analysis of data on young people 
attending the Jigsaw service provides a useful insight into 
the mental health issues experienced by this cohort. In the 
first instance, it is positive to learn that these young people 
were open to discussing and seeking support for their mental 
health, and particularly encouraging that almost a third of 
the cohort who engaged directly with the service referred 
themselves. Additionally encouraging, and a point picked 
up on by the authors, was that almost half of all young 
people presenting were young males, who are traditionally 
less likely to seek psychological help compared to their 
female counterparts. The number of different mental health 
problems reported by these young people is also concerning. 
However, it must be noted that these reported problems 
were not diagnosed as disorders and, again, it is positive 
that these young people are receiving an early intervention 
which may prevent the condition deteriorating. Finally, 
although the reported reductions in psychological distress 
among some of these young people post-intervention could 
not be attributed solely to the effect of the intervention, it 
remains positive that for some their distress is being reduced, 
regardless of the cause or causes. 
(Martin Keane) 
1. O’Keeffe L, O’Reilly A, O’Brien G, Buckley R and Illback R 
(2015) Description and outcome evaluation of Jigsaw: an 
emergent Irish mental health early intervention programme 
for young people. Irish Journal of Psychological Medicine 
(32): 71–77. http://www.drugsandalcohol.ie/23291/
Tusla publishes first corporate plan 
Tusla, the Child and Family Agency, came into existence on 1 
January 2014 under the Child and Family Agency Act 2013. 
Merging the HSE Children and Family Service, the Family 
Support Agency and the National Education and Welfare 
Board, Tusla is the dedicated state agency responsible for 
improving the well-being of and outcomes for children. 
Tusla’s services include child welfare and protection services, 
family resource centres, pre-school inspection, educational 
welfare responsibilities, alternative care (e.g. foster care, 
residential care, special care and aftercare), domestic, sexual 
and gender-based violence services, psychological welfare, 
assessment, consultation, therapy and treatment services, 
and adoption services. 
In February 2015 Tusla published its first corporate plan for 
the period 2015–2017.1 The corporate plan was developed 
in four stages – stakeholder consultation, development of a 
social change model, creation of a vision, mission and values, 
followed by a set of strategic objectives. These stages are 
outlined below.
Social change model
Feedback from an extensive a stakeholder consultation, the 
first stage in developing the corporate plan, was used to 
develop a ‘social change model’ to map out a path to Tusla’s 
desired long-term outcomes. The social change model is a 
process whereby the social problem that an organisation 
needs to address is identified and the various levers within 
that organisation’s control that can be used to affect the 
change are isolated. The social problem that Tusla needs to 
address was identified as: 
A lack of long-term, evidence-informed planning and insufficient 
resources leads to disjointed services and inadequate supports 
for children and families.
Having defined the problem, the social change model was 
used to identify the long-term outcomes that Tusla needs to 
achieve for children and families over the next seven to ten 
years. The first three years will focus on putting in place the 
foundation stones to enable Tusla’s medium and longer term 
outcomes to be achieved (see Table 1). 
Vision, mission and values
Tusla’s vision, mission and values outline what the 
organisation wants to achieve, how it wants to achieve it and 
how it wants to go about its business.
 ■ Vision: All children are safe and achieving their full 
potential.
 ■ Mission: With the child at the centre, our mission is to 
design and deliver supportive, coordinated and evidence-
informed services that strive to ensure positive outcomes 
for children.
 ■ Values: courage and trust; respect and compassion; 
empathy and inclusion.
Strategic objectives
Tusla will start work towards achieving its desired outcomes 
by delivering on eight strategic objectives due to be 
completed in the next three years, i.e. more specific and 
time-bound targets than the higher-level outcomes. The 
strategic objectives are: 
1. Improve the quality and focus of the delivery of services 
for children and families.
2. Develop the governance structures, processes and 
supporting infrastructure to ensure that Tusla is in a 
position to carry out its functions in an effective and 
efficient manner.
Young people & mental health (continued)
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3. Establish a new and distinct values-based culture that 
empowers children and families through high-quality 
services.
4. Develop an organisation that lives within its means and 
utilises its resources in an efficient and cost-effective 
manner.
5. Develop a workforce that is valued and supported within 
a learning organisation.
6. Position the Agency as a responsive, trustworthy and 
respected body with its own unique identity.
7. Build on our research strategy to develop policy and 
enable evidence-based decision-making and high-quality 
service delivery.
8. Ensure a strategic approach to quality assurance, 
information management and risk management 
that supports continuous improvement and good 
governance.
In conclusion, the plan outlines two key systems that will  
be put in place to ensure delivery – a corporate risk register, 
and a quality assurance function that will report regularly  
on progress. 
(Brigid Pike)
1. Tusla – Child and Family Agency (2014) Corporate plan 
2015–2017 Dublin: Tusla. http://www.drugsandalcohol.
ie/23497/ 
Short-term outputs
(1–3 years)
Medium-term outputs
(4–6 years)
Long-term outputs
(7–10 years)
A. Tusla’s child protection processes and 
systems are responding to children at 
risk in a timely manner.
A. Revised systems are significantly reduc-
ing the numbers of children at risk.
A. All children are safe from abuse, 
neglect and exploitation.
B. All processes and systems underpin-
ning children and family policy and 
services are evidence-informed.
B. Children and family services are more 
user-friendly, strengths-based and co-
produced.
B. All children and families are capable 
of making informed decisions about 
their health and lifestyles.
C. A targeted range of family and par-
enting supports.
C. Children and family services are prop-
erly coordinated and aligned.
C. All parents are providing stable and 
loving home environments in which 
children thrive.
D. Attendance, participation and reten-
tion in full-time education is embed-
ded in service delivery for all children.
D. The benefits of increased child and 
family participation in education is 
acknowledged across all sectors of 
society.
D. All children and their families are 
actively engaged in their education.
Table 1: Pathways to achieving desired long-term outcomes, Tusla 2015–2025
Source: Tusla (2014) p. 18
NDC drugs library – new resource  
for practitioners
Every year we add hundreds of new articles and reports to 
our library collection. In order to help relieve information 
overload we have a number of summarised aids, such as 
Drugnet Ireland, NDC newsletter, and factsheets. 
Practitioners in the alcohol and drugs area have limited time 
to keep up-to-date with research and evidence, so need 
easy access to research on subjects related to their work or 
profession. In order to facilitate this, the NDC librarians have 
developed a ‘practitioner’ resource. The homepage 
http://www.drugsandalcohol.ie/practitioners has links 
to a number of subject areas. The ‘key Irish data’ 
link and those on the bottom row are relevant 
to most workers. Clicking on a link will show you 
recent Irish and international articles and reports on 
that subject. 
With the help of some wonderful advisers from 
social work and social care work professions, we 
have also developed pages for specific professions. 
We hope to add more of these in the future. Each 
of these pages lists key documents and has links to 
subjects of particular interest to that profession.
The resource includes a page called ‘doing research’, 
which has links to useful online tools providing 
help on finding and using information for research. We are 
interested in collecting and making available local Irish drug 
or alcohol research done by those working in the area. If 
practitioners are doing any such research, even a small piece 
in their organisation, they can submit it to us at ndc@hrb.ie 
We would also welcome feedback with recommendations for 
key documents, subject areas and anything else practitioners 
would like to see in their resource.
TUSLA Corporate Plan (continued)
24
drugnet 
Ireland
EMCDDA Insights 
In April 2015 the EMCDDA published the 17th in its Insight 
series – Treatment of cannabis-related disorders in Europe. 
Opening with an overview of cannabis use and its health 
effects, the report presents the latest evidence underpinning 
interventions, maps the availability and provision of cannabis 
treatment in 30 countries (including Ireland), and compares 
treatment needs with provision. 
‘Treatment for cannabis-related problems’, states the report, 
‘relies primarily on psychosocial approaches combining 
elements of classical psychotherapy with social support 
and care.’ To highlight the interventions most likely to 
succeed, the study weighs up the published evidence on a 
range of treatment programmes. It differentiates between 
those targeting adults and those targeting adolescents, 
and between cannabis-specific and general substance-use 
programmes. Telephone and online approaches are among 
those examined. 
No evidence is reported showing the superiority of specific 
over general treatment, as ‘both approaches can work’. 
Comparing indicators of treatment needs with treatment 
provision, the report concludes that, despite exceptions, ‘the 
overall situation in Europe looks positive’.
First published in 1997, EMCDDA Insights are topic-based 
reports that bring together current research and study 
findings on a particular issue in the drugs field. 
The Insight reports are available for download  
at http://www.emcdda.europa.eu/publications/ 
From Drugnet Europe
New EMCDDA review studies effectiveness of overdose 
antidote, naloxone 
Cited from Drugnet Europe No 89 
January–March 2015
Can naloxone provided in the community help reduce the 
thousands of drug-induced deaths recorded in Europe every 
year? This is the question explored in a new EMCDDA Paper 
released in January: Preventing fatal overdoses: a systematic 
review of the effectiveness of take-home naloxone (1). 
Naloxone — a pharmaceutical drug used to reverse the 
effects of opioid overdose — has been used in emergency 
medicine (e.g. by ambulance crews, hospital emergency-
room teams) for over 40 years. But as many overdoses occur 
in the presence of drug users’ family members or peers, 
empowering bystanders to act effectively, before emergency 
services arrive at the scene, can save lives (2). 
Following pilot initiatives in the 1990s, measures to scale up 
naloxone availability to those likely to witness an overdose 
have emerged in the last decade. This has been driven partly 
by the epidemic of opioid-related deaths (heroin and non-
heroin) in the USA (3). 
Analysing 21 studies conducted in four countries — Canada, 
Germany, UK and the USA — the new review examines the 
latest evidence on the role of take-home naloxone (THN) 
in reducing opioid overdose fatalities. It concludes that 
THN provision, delivered with educational and training 
interventions, can be effective in reducing overdose-related 
deaths and improving knowledge on the signs of overdose 
and the correct management of patients. 
Listed by the World Health Organization (WHO) as an 
‘essential medicine’, naloxone is available in injectable 
form, with non-injecting administration under investigation. 
Programmes and trials with THN distribution are currently 
run in seven European countries: Denmark, Germany, 
Estonia, Spain, Italy, UK and Norway (see Annex 3 of review). 
Since September 2013, Estonia has offered a naloxone 
programme to tackle the sharp rise in deaths caused by illicit 
use of the synthetic opioid fentanyl. In 2014, Norway began 
a pilot of a nasal spray naloxone programme. 
The report shows how evidence supports THN provision as 
part of a comprehensive harm reduction response. WHO 
guidelines on community-based naloxone provision were 
launched in November 2014 and a number of European 
countries have now developed national guidelines (4). 
Knowledge exchange on THN is important to allow potential 
implementers to take informed decisions (5). 
Drug use is one of the major causes of mortality among 
young people in Europe. Overall, some 6 100 overdose 
deaths were reported in Europe in 2013. Substances 
associated with the risk of overdose include: opioids (non-
medical or prescribed); benzodiazepines and synthetic 
opioids (e.g. fentanyls). 
Marica Ferri and Lucas Wiessing 
(1) www.emcdda.europa.eu/publications/emcdda-papers/
naloxone-effectiveness 
(2) www.emcdda.europa.eu/topics/pods/preventing-
overdose-deaths (EMCDDA Perspectives on drugs). 
(3) www.whitehouse.gov/ondcp/national-drug-control-
strategy 
(4) www.emcdda.europa.eu/best-practice/guidelines 
(5) The role of take-home naloxone (THN) in reducing 
opioid-related fatalities was the focus of an EMCDDA 
meeting held in Lisbon on 14 October 2014. www.emcdda.
europa.eu/events/2014/meetings/naloxone See video at 
www.youtube.com/user/emcddatube
Dangerous drug PMMA makes a comeback 
Cited from Drugnet Europe No 89 
January–March 2015
Over the last three months, PMMA — a stimulant-type drug 
of the phenethylamine group — has been seen to be making 
a comeback on the European illicit drug market in ecstasy 
tablets bearing a Superman logo. Since the end of December 
2014, these tablets have been associated with the deaths of 
at least six individuals in Europe.  
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PMMA (para-methoxymethamphetamine) underwent a 
formal EMCDDA risk assessment in 2001 and, following a 
Council Decision in February 2002, was subjected to control 
measures and criminal penalties across the EU Member 
States (1)(2)(3). 
PMMA is considered to elicit entactogenic effects in users 
— similar to those provoked by MDMA. However, the 
substance has weaker stimulant effects, is slower-acting and 
more toxic than MDMA, particularly when combined with 
other substances. Users believing tablets to be MDMA, and 
experiencing the weak stimulant effects and delayed onset of 
action, may believe that they have consumed ‘weak ecstasy’. 
As a result, they may be tempted to re-dose, increasing the 
risk of adverse effects and possible overdose. 
From 1993 to 2013, the EMCDDA is aware of approximately 
47 deaths in 10 European countries associated with the use 
of PMMA, with a notable cluster in Norway in late 2010. 
Rachel Christie, Andrew Cunningham and Roumen Sedefov 
(1) Risk assessment report at www.emcdda. europa.eu/
publications/risk-assessments/pmma 
(2) www.emcdda.europa.eu/news/2002 
(3) www.emcdda.europa.eu/news/2012/10 
 
 
 
 
 
 
Mortality among drug users in Europe 
Cited from Drugnet Europe No 89 
January–March 2015
Drug use is one of the major causes of mortality among 
young people in Europe, both directly through overdose 
(drug-induced deaths) and indirectly through drug-related 
diseases, accidents, violence and suicide. Every year, over 
6 000 drug users die of overdose in the EU, most of these 
deaths involving opioids and occurring among problem drug 
users. To gain a clearer picture of the overall number of lives 
lost due to drug use in Europe, this new EMCDDA paper 
builds on the results of earlier work investigating ‘all-cause’ 
mortality among problem drug users. By linking data on 
entrants to drug treatment programmes with information 
from death registries, mortality cohort studies can determine 
death rates from all causes within the study population. 
Available in English at: www.emcdda.europa.eu/publications/
emcdda-papers 
Drugnet Europe is the quarterly newsletter of the European 
Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). It is available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future 
issues, please contact:
Health Research Board, Grattan House, 67–72 Lower 
Mount Street, Dublin 2. 
Tel: 01 2345 148; Email: drugnet@hrb.ie
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Recent publications
The following abstracts are cited from recently published journal 
articles relating to the drugs situation in Ireland.
Depression and alcohol withdrawal syndrome: is 
antidepressant therapy associated with lower rates of 
hospital readmission?
Schoonover K, Burton MC, Larson SA, Cha SS, Lapid MI 
(2015) Irish Journal of Medical Science Early online 
http://www.drugsandalcohol.ie/23871/ 
This study highlights the high frequency of depression 
and antidepressant use in patients admitted with Alcohol 
withdrawal syndrome (AWS) to an acute care hospital. As 
alcohol withdrawal is associated with increased morbidity 
and mortality and depression is common in those with 
alcohol use disorder, further research is necessary to clarify 
the optimal treatment of comorbid depression and alcohol 
use disorder in reducing these revolving door admissions.
Three hundred and twenty-two patients were admitted with 
AWS during the study period. One hundred and sixty-one 
patients (50%) had no history of depression, 111 patients 
(34%) had a history of depression and antidepressant use, 
and 50 patients (16%) had a history of depression and 
no antidepressant use. There was no significant difference 
in the number of hospitalizations for AWS between these 
three groups. Patients with a history of depression on 
antidepressant medication were more likely to be retired or 
work disabled compared to the other two groups (p<0.05). 
The antidepressant class most commonly used was  
SSRI (63 %).
Prevalence and predictors of smoking in ‘smoke-free’ 
bars. Findings from the International Tobacco Control 
(ITC) Europe surveys 
Nagelhout GE, Mons U, Allwright S, Guignard R, Beck 
F, Fong GT, de Vries H, Willemsen MC (2011) Science & 
Medicine (72/10): 1643–1651. 
http://www.tara.tcd.ie/handle/2262/56861
http://www.drugsandalcohol.ie/23855/
National level smoke-free legislation is implemented to 
protect the public from exposure to second-hand tobacco 
smoke (SHS). The first aim of this study was to investigate 
how successful the smoke-free hospitality industry legislation 
in Ireland (March 2004), France (January 2008), the 
Netherlands (July 2008), and Germany (between August 
2007 and July 2008) was in reducing smoking in bars. The 
second aim was to assess individual smokers’ predictors of 
smoking in bars post-ban. The third aim was to examine 
country differences in predictors and the fourth aim was 
to examine differences between educational levels (as an 
indicator of socioeconomic status). This study used nationally 
representative samples of 3147 adult smokers from the 
International Tobacco Control (ITC) Europe Surveys who 
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were surveyed pre- and post-ban. The results reveal that 
while the partial smoke-free legislation in the Netherlands 
and Germany was effective in reducing smoking in bars 
(from 88% to 34% and from 87% to 44%, respectively), 
the effectiveness was much lower than the comprehensive 
legislation in Ireland and France which almost completely 
eliminated smoking in bars (from 97% to 3% and from 84% 
to 3% respectively). Smokers who were more supportive 
of the ban, were more aware of the harm of SHS, and 
who had negative opinions of smoking were less likely to 
smoke in bars post-ban. Support for the ban was a stronger 
predictor in Germany. SHS harm awareness was a stronger 
predictor among less educated smokers in the Netherlands 
and Germany. The results indicate the need for strong 
comprehensive smoke-free legislation without exceptions. 
This should be accompanied by educational campaigns 
in which the public health rationale for the legislation is 
clearly explained.
Educational interventions: equipping general practice  
for youth mental health and substance abuse. A 
discussion paper 
O’Regan A, Schaffalitzky E, Cullen W (2015) Irish Journal of 
Medical Science Early online 
http://www.drugsandalcohol.ie/23824/
Youth mental health issues and substance abuse are 
important causes of morbidity and mortality in Ireland. 
General practice is a frequent point of contact for young 
people, however, reluctance amongst this population group 
to disclose mental health issues and a lack of confidence 
amongst GPs in dealing with them have been reported. 
Focussed training interventions with formal evaluation of 
their acceptability and effectiveness in achieving learning, 
behavioural change and impact on clinical practice 
are needed.
This paper aims to examine the literature on general practice 
in youth mental health, specifically, factors for an educational 
intervention for those working with young people in 
the community.
This review paper was carried out by an online search of 
PubMed on the recent literature on mental health and 
on educational interventions for health care workers in 
primary care.
A number of papers describing educational interventions 
for GPs and primary care workers were found and analysed. 
Key areas to be addressed when identifying and treating 
mental health problems were prevention, assessment, 
treatment, interaction with other services and ongoing 
support. Important elements of an educational intervention 
were identified.
Several barriers exist that prevent the identification and 
treatment of these problems in primary care. An educational 
intervention should help GPs address these issues. Any 
intervention should be rigorously evaluated.
With the shift in services to the community in Irish health 
policy, the GP with appropriate training could take the lead 
in early intervention in youth mental health and addiction. 
 
 
 
 
Ireland’s Public Health (Alcohol) Bill: policy window or 
political sop? 
Butler S (2015) Contemporary Drug Problems Early online 
http://www.drugsandalcohol.ie/23822/
In the wake of the Steering Group Report on a National 
Substance Misuse Strategy in 2012, the Irish government 
announced in October 2013 that it had approved a number 
of alcohol policy measures to be incorporated into a Public 
Health (Alcohol) Bill to be drafted and enacted as quickly 
as possible. Against a historic backdrop of previous alcohol 
policy proposals in Ireland in recent decades, this article 
looks critically at this recent development with a view to 
determining to what extent it represents, in Kingdon’s 
terms, a ‘‘policy window’’ for the public health approach to 
alcohol issues. It is argued that while some specific public 
health measures may be introduced, the various ‘‘streams’’ 
of the Irish policy process have not joined together in 
an unambiguous, consensual acceptance of the public 
perspective on alcohol, and that the ‘‘politics stream’’ has 
not to date deemed this perspective to be consonant with 
the ‘‘national mood.’’
Increasing the potential for diversion in the Irish criminal 
justice system: the role of the Garda Síochána adult 
cautioning scheme 
Tolan G, Seymour M (2014) Irish Journal of Applied Social 
Studies 14 (1) 
http://arrow.dit.ie/cgi/viewcontent.cgi?article=12...
http://www.drugsandalcohol.ie/23801/
Established in 2006, the Garda Síochána Adult Caution 
Scheme provides a mechanism to divert adult offenders, 
aged 18 years and over, from the criminal justice system 
by way of a formal police caution in lieu of prosecution 
before the courts. Drawing on statistical data provided 
by the Central Statistics Office, this paper explores the 
use of the scheme over a five year period from 2006 to 
2010. It identifies the types of offences for which cautions 
are most commonly administered, the age and gender 
profile of offenders involved, variability in the application 
of the scheme across the country, and the extent to which 
offenders come to the attention of An Garda Síochána 
post-caution. Overall, the paper analyses the role of 
adult cautioning in the Irish context and provides some 
observations on the potential for increased diversion, 
through expanding the remit of the scheme in future years.
Close practice encounters of the teenage kind 
Wallace V, Doorley E, Wallace D, Hollywood B (2015) Forum 
(32/4): 12–14
http://www.drugsandalcohol.ie/23769/
Research by GPs in Ballymun provides an informative 
snapshot of the health needs of teenage patients and 
some important pointers from dealing with this often 
vulnerable group.
Substance misuse and recording of this issue was reviewed. 
In general, it was noted that whether or not the person 
attending used alcohol, smoked cigarettes or used other 
substances was not recorded. No reference was made to 
alcohol in any of the 380 teenagers’ records, but that this 
was not recorded does not in our view indicate that none of 
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these 380 teenagers drinks alcohol. Seven teenagers were 
noted to be smokers of cigarettes, seven were noted to be 
smokers of hash, and there was not mention in the clinical 
records of other drugs being used.....
Benzodiazepine use in a methadone maintained opiate 
dependent cohort in Ireland
Gilroy D, O’Brien S, Barry J, Ivers JH, Whiston L, Keenan 
E, Darker CD (2014) Heroin Addiction and Related Clinical 
Problems (16/2): 23–30
http://www.drugsandalcohol.ie/23737/
Benzodiazepines (BZDs) are one of the most widely abused 
substances by opioid dependent patients. 
This research aims to identify patterns of BZD use in 
methadone maintained opioid dependent patients attending 
an addiction treatment clinic in Dublin, Ireland. Methods: 
Patients (n=78) testing positive for BZDs by urinalysis 
completed a face-to-face survey.
Daily BZD use was reported by 70.1% (n=54) with 67.9% 
(n=53) consuming up to 5 tablets a day. A BZD prescription 
was provided for 50% (n=39) and 61.5% (n=48) used illicit 
BZDs. The primary BZD of use was Diazepam reported by 
93.6% (n=73) of patients. Analysis showed source of BZDs 
is related to frequency of consumption [X2(2)= 10.98, p < 
0.01] and use of others drugs [X2(2)= 6.97, p< 0.04].
Source of BZDs is associated with frequency of consumption 
and use of other drugs. Current patterns of BZD use is 
between 1 to 5 years which is considerably longer than 
recommended duration of BZD use.
A survey of patients on methadone programmes in 
Wheatfield Prison, Dublin, Ireland 
Galander T, Rosalim J, Betts-Symonds G, Scully M (2014) 
Addiction and Related Clinical Problems (16/2): 17–22
http://www.drugsandalcohol.ie/23736/
This article is described in a report ‘Patients on methadone 
programmes, Wheatfield prison’ elsewhere in this issue of 
Drugnet Ireland.
The prevalence of common mental and substance use 
disorders in general practice: a literature review and 
discussion paper
Klimas J, Neary A, McNicholas C, Meagher D, Cullen W 
(2014) Mental Health and Substance Use (7/4): 497–508 
http://www.drugsandalcohol.ie/23733/
Enhanced primary care management of common mental 
and substance use disorders is a key healthcare target. 
Though primary care may be well placed to achieve this 
target, a greater understanding of the prevalence and profile 
of common mental and substance use disorders in primary 
care settings is needed. We searched the MEDLINE database 
(2002–2012) to provide an update on biomedical literature 
describing the prevalence of common mental and substance 
use disorders in European general practice. Following 
‘PRISMA’ guidelines, 17 studies were kept for qualitative 
synthesis. Prevalence, profile, screening instruments, 
associated co-morbidities, and gender distribution were 
tabulated. Depending on the screening method, the 
prevalence of common mental and substance use disorders 
ranged from 10.4% (Luxembourg) to 53.6% (Spain). Mood 
disorders were the most common. High co-morbidity with 
anxiety and somatisation hindered early identification and 
management. The continuing burden of common mental 
and substance use disorders, coupled with poor identification 
described in the updated EU biomedical literature, suggests 
that the unmet need for health care – identified by the 
World Health Organization a decade ago – remains unmet. 
Understanding the prevalence of common mental and 
substance use disorders, associated morbidity, and the extent 
to which general practice represents an important catchment 
mechanism can enhance their management at this level. 
General practitioners should be trained in accurate screening. 
Short screening instruments for general practitioners should 
be unified and promoted.
Pregabalin for detoxification from opioids: a single  
case study 
Scanlon A (2014) Mental Health and Substance Use (7/4): 
263–285
http://www.drugsandalcohol.ie/23730/
The objective of this research is to develop a clearer 
understanding as to whether pregabalin is an appropriate 
and efficacious method to treat individuals presenting with 
withdrawal symptoms following cessation of opiate drug 
abuse. The focus of this study is to identify the value of a 
particular medicine within a particular case, representative 
of a particular group. The author has identified the 
participant in advance of the study to meet criteria of opiate 
dependence and will explore the dynamics of the case 
in great detail. The sample for this study was a purposive 
sample of one female lady who has been diagnosed as 
opiate dependent (DSM-IV criteria). The analysis of data 
is an inductive cyclical process that involves a process of 
observing the particular phenomenon from more general 
to specific observations. Data analysis commenced with 
interviews with the patient with emphasis on history 
taking, information gathering, and treatment. Data 
analysis will include a cross-tabulation of the subjective 
and objective data and the measurement of change 
using an evidence-based rating scale. The Clinical Opiate 
Withdrawal Scale was used to compare the analysis of the 
presenting symptoms longitudinally. From the objective 
data, it was a reasonable assumption that the symptoms of 
withdrawal were controlled better with pregabalin for the 
subject of this study. The patient acknowledged that this 
detoxification episode was ‘a lot easier than previous ones’. 
It was a positive response in relation to the prescription of 
pregabalin that she first of all completed the prescribed 
detoxification regime and second it was acknowledged that 
the symptoms were alleviated more effectively than previous 
detoxification episodes.
Psychological distress and lifestyle of students: 
implications for health promotion
Deasy C, Coughlan B, Pironom J, Jourdan D, Mcnamara PM 
(2015) Health Promotion International (30/1): 77–87 
http://www.drugsandalcohol.ie/23717
Poor diet, physical inactivity, tobacco smoking and alcohol 
consumption are major risk factors for chronic disease 
and premature mortality. These behaviours are of concern 
among higher education students and may be linked to 
psychological distress which is problematic particularly 
for students on programmes with practicum components 
such as nursing and teaching. Understanding how risk 
behaviours aggregate and relate to psychological distress 
Recent publications (continued)
28
drugnet 
Ireland
and coping among this population is important for health 
promotion. This research examined, via a comprehensive 
survey of undergraduate nursing/midwifery and teacher 
education students’ (n = 1557) lifestyle behaviour (Lifestyle 
Behaviour Questionnaire), self-reported psychological 
distress (General Health Questionnaire) and coping processes 
(Ways of Coping Questionnaire). The results showed that 
health-risk behaviours were common, including alcohol 
consumption (93.2%), unhealthy diet (26.3%), physical 
inactivity (26%), tobacco smoking (17%), cannabis use 
(11.6%) and high levels of stress (41.9%). Students tended 
to cluster into two groups: those with risk behaviours 
(n=733) and those with positive health behaviours (n=379). 
The group with risk behaviours had high psychological 
distress and used mostly passive coping strategies such as 
escape avoidance. The potential impact on student health 
and academic achievement is of concern and suggests the 
need for comprehensive health promotion programmes to 
tackle multiple behaviours. As these students are the nurses 
and teachers of the future, their risk behaviours, elevated 
psychological distress and poor coping also raise concerns 
regarding their roles as future health educators/promoters. 
Attention to promotion of health and well-being among this 
population is essential.
Young people in drug treatment in Ireland: their views 
on substance use aetiology, trajectory, parents’ role in 
substance use and coping skills
Darker CD, Palmer D, O’Reilly G, Whiston L and Smyth B 
(2014) Irish Journal of Psychological Medicine Available on CJO 
2014 doi:10.1017/ipm.2014.77 
http://www.drugsandalcohol.ie/23180/
This article is described in a report 'Young people in drug 
treatment' elsewhere in this issue of Drugnet Ireland.
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June
26 June 2015
International Day against Drug Abuse and  
Illicit Trafficking
Further information: http://www.unodc.org/drugs/en/
june-26/index.html
Each year, 26 June is International Day against Drug Abuse 
and Illicit Trafficking. Established by the United Nations 
General Assembly in 1987, this day serves as a reminder 
of the goals agreed to by member states of creating an 
international society free of drug abuse. The United Nations 
Office on Drugs and Crime (UNODC) selects themes for 
the International Day and launches campaigns to raise 
awareness about the global drug problem. Health is the 
ongoing theme of the world drug campaign.
September
23 September 2015
Lisbon addictions conference 2015 
Venue: Lisbon, Portugal
Further information: http://www.lisbonaddictions.eu/start 
The first European conference on addictive behaviours 
and dependencies will be held in Lisbon on 23–25 
September 2015.
This will be a comprehensive and multi-disciplinary 
event, showcasing leading European addiction research 
in the specialist areas of illicit drugs, alcohol, tobacco, 
gambling and other addictive behaviours. It will address 
new challenges and cover developing fields such as new 
psychoactive substances, online sales and gambling, 
cannabis legalisation and alcohol pricing.
This conference will provide a unique networking 
opportunity for researchers, practitioners and policy experts 
across countries and disciplines to discuss latest findings on 
the prevention, treatment and control of addiction. It is the 
ideal venue to forge collaborative partnerships and explore 
funding opportunities.
This conference is jointly organised by the Portuguese 
General Directorate for Intervention on Addictive 
Behaviours and Dependencies (Serviço de Intervenção nos 
Comportamentos Aditivos e nas Dependências — SICAD), 
the journal Addiction, the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) and the International 
Society of Addiction Journal Editors (ISAJE). It will take 
place at the FIL Expo conference centre in the beautiful city 
of Lisbon.
Upcoming events
